354896	176	224	sinoatrial and atrioventricular nodal pacemakers	MESH:D013615
354896	331	347	bradyarrhythmias	MESH:D001919
1378968	11	25	uninephrectomy
1378968	78	91	renal failure	MESH:D051437
1378968	127	138	nephropathy	OMIM:161900
1378968	184	198	uninephrectomy
1378968	255	281	glomerular hyperfiltration	MESH:D007673
1378968	309	322	renal failure	MESH:D051437
1378968	324	350	Newborn female Wistar rats	MESH:D011906
1378968	447	449	HP	MESH:C537262
1378968	975	986	proteinuria	MESH:D011507
1378968	991	1012	systolic hypertension	MESH:D054160
1378968	1016	1045	absence of glomerulosclerosis	MESH:D003928
1378968	1087	1100	renal failure	MESH:D051437
1378968	1280	1282	HP	MESH:C537262
1378968	1390	1401	nephropathy	OMIM:161900
1378968	1466	1477	proteinuria	MESH:D011507
1378968	1482	1512	arterial systolic hypertension	MESH:C536282
1378968	1539	1552	renal failure	MESH:D051437
1378968	1706	1738	nonfiltrating atubular glomeruli
1420741	292	307	Crohn's disease	MESH:D003424
1420741	1440	1466	inflammatory bowel disease	MESH:D015212
1601297	33	50	myocardial injury	MESH:D009202
1601297	305	322	myocardial injury	MESH:D009202
1601297	334	355	myocardial infarction	MESH:D009203
1601297	357	365	ischemia	MESH:D007511
1967484	18	34	tardive dystonia	MESH:D009069
1967484	204	240	sulpiride-induced tardive dyskinesia	MESH:D009069
1967484	345	363	segmental dystonia	MESH:C537538
1967484	456	490	sulpiride-induced tardive dystonia	MESH:D009069
2234245	314	341	visual or auditory toxicity	MESH:D056486
2234245	522	548	tritan-type dyschromatopsy	MESH:D003117
2234245	586	599	visual acuity	MESH:D012640
2234245	604	631	pigmentary retinal deposits	MESH:D058225
2234245	697	724	neurosensorial hearing loss	MESH:D034381
2385256	0	17	Myasthenia gravis	MESH:D009157
2385256	119	140	neuromuscular disease	MESH:D009468
2385256	844	861	myasthenia gravis	MESH:D009157
2385256	1078	1116	disorder of neuromuscular transmission	MESH:D020511
2505783	375	395	hemorrhagic cystitis	MESH:D003556
2505783	476	490	bladder damage	MESH:D001925
2515254	557	565	migraine	MESH:D008881
2572625	20	35	acute hepatitis	MESH:D017114
2572625	83	98	acute hepatitis	MESH:D017114
2572625	104	137	extensive hepatocellular necrosis	MESH:D006528
2572625	432	441	hepatitis	MESH:D006505
2572625	494	509	acute hepatitis	MESH:D017114
2632720	0	21	Arterial hypertension	MESH:C536282
2632720	467	507	deoxycorticosterone and 11-deoxycortisol	MESH:C536096
2632720	821	859	mineralocorticoid-related hypertension	MESH:D000312
2670794	86	105	renal insufficiency	MESH:D051437
2670794	312	331	renal insufficiency	MESH:D051437
2670794	503	522	renal insufficiency	MESH:D051437
2670794	1480	1517	deposited and thus less kidney damage	MESH:D001925
2696505	518	554	cardiac output; rebound hypertension	MESH:D002303
2924746	243	246	AED
2924746	767	770	MES	MESH:C536133
2924746	745	765	maximal electroshock
2924746	1134	1137	CBZ
2951327	588	599	tachycardia	MESH:D013610
2951327	893	911	atrial natriuretic	MESH:D001281
2951327	1175	1193	atrial natriuretic	MESH:D001281
3192036	175	190	choriocarcinoma	MESH:D002822
3192036	665	681	clinical picture	MESH:D059466
3192036	730	759	choriocarcinomic tissue plugs	MESH:D059226
3192036	844	868	extensive tumor necrosis	MESH:D009336
3192036	961	966	tumor	MESH:D009369
3192036	1009	1014	tumor	MESH:D009369
3192036	1107	1112	tumor	MESH:D009369
3192036	1224	1232	embolism	MESH:D004617
3192036	1273	1281	necrosis	MESH:D009336
3192036	1342	1347	tumor	MESH:D009369
3409645	0	18	Sexual dysfunction	MESH:D012735
3409645	39	48	arthritis	MESH:D001168
3409645	70	79	arthritis	MESH:D001168
3409645	84	102	sexual dysfunction	MESH:D012735
3409645	144	164	rheumatoid arthritis	MESH:D001172
3409645	166	180	osteoarthritis	MESH:D010003
3409645	185	204	spondyloarthropathy	MESH:D013167
3409645	371	375	AMHS
3409645	340	369	Azrin Marital Happiness Scale	MESH:C538175
3409645	378	397	Sexual dysfunctions	MESH:D012735
3409645	853	862	arthritis	MESH:D001168
3409645	887	905	sexual dysfunction	MESH:D012735
3412544	23	40	urothelial cancer	MESH:D009369
3412544	44	68	renal papillary necrosis	MESH:D007681
3412544	93	117	renal papillary necrosis	MESH:D007681
3412544	121	147	cancer of the renal pelvis	MESH:D010386
3412544	149	166	ureter or bladder	MESH:D014516
3412544	327	351	renal papillary necrosis	MESH:D007681
3412544	445	483	cancer of the renal pelvis and bladder	MESH:D010386
3412544	496	511	ureteric cancer	MESH:D014516
3412544	608	632	renal papillary necrosis	MESH:D007681
3412544	649	656	cancers	MESH:D009369
3412544	712	718	cancer	MESH:D009369
3425586	0	46	Dapsone-associated Heinz body hemolytic anemia	OMIM:140700
3425586	164	191	Heinz body hemolytic anemia	OMIM:140700
3425586	397	420	decreased GSH stability	OMIM:103900
3425586	920	936	hemolytic anemia	MESH:D000743
3437726	186	209	coronary artery disease	MESH:D003324
3437726	230	233	CCU
3437726	287	321	impairment of ventricular function	OMIM:608852
3437726	938	1007	debrisoquine/sparteine type polymorphism of oxidative drug metabolism	OMIM:608902
3693336	186	209	organic mental disorder	MESH:D019965
3780846	800	802	AS	MESH:D017204
3780846	803	805	KS
3780846	1240	1242	AS	MESH:D017204
3780846	1243	1245	KS
3780846	1665	1667	AS	MESH:D017204
3780846	1668	1670	KS
3800626	12	22	neuropathy	MESH:D003929
3800626	70	86	fibrous myopathy	MESH:D010411
3800626	88	104	Fibrous myopathy	MESH:D010411
3800626	197	207	neuropathy	MESH:D003929
3800626	263	271	myopathy	MESH:D009135
3800626	365	424	fibrous myopathy of triceps and deltoid muscles bilaterally	MESH:D012021
3800626	620	636	fibrous myopathy	MESH:D010411
3827439	145	158	renal failure	MESH:D051437
3827439	268	281	renal failure	MESH:D051437
3827439	370	387	renal dysfunction	MESH:C535382
3827439	445	470	effective arterial volume	MESH:D007088
3827439	536	555	acute renal failure	MESH:D058186
3997294	0	11	Pneumonitis	MESH:D011014
3997294	54	64	neuropathy	MESH:D003929
3997294	107	125	sinuatrial disease	MESH:D004194
3997294	279	295	tachyarrhythmias	MESH:D013610
3997294	310	321	pneumonitis	MESH:D011014
3997294	393	403	neuropathy	MESH:D003929
3997294	593	615	amiodarone pneumonitis	MESH:D011014
4071154	21	40	renal insufficiency	MESH:D051437
4071154	111	124	renal failure	MESH:D051437
4071154	130	142	hyperkalemia	MESH:D006947
4071154	161	170	cirrhosis	MESH:D005355
4071154	427	458	endogenous renal prostaglandins	MESH:D003866
4071154	657	676	acute renal failure	MESH:D058186
6229975	63	84	myocardial infarction	MESH:D009203
6229975	148	169	myocardial infarction	MESH:D009203
6229975	500	511	bradycardia	MESH:D001919
6229975	654	675	borderline heart size	MESH:D012569
6286738	128	151	prolonged hypercalcemia	MESH:D006934
6286738	153	170	hyperphosphatemia	MESH:D054559
6287825	166	185	malignant disorders	MESH:D016609
6287825	319	329	neuropathy	MESH:D003929
6287825	368	392	Guillain-Barr   syndrome	MESH:D020275
6287825	483	493	neuropathy	MESH:D003929
6287825	506	516	neuropathy	MESH:D003929
6287825	536	573	deficiency of thiamine and riboflavin	MESH:D012257
6287825	617	653	sensory and sensori-motor neuropathy	MESH:D015417
6287825	655	672	Diabetes mellitus	MESH:D003920
6287825	696	716	autonomic neuropathy	MESH:D003929
6287825	772	782	neuropathy	MESH:D003929
6287825	836	846	neuropathy	MESH:D003929
6287825	1030	1040	neuropathy	MESH:D003929
6287825	1059	1105	Heredofamilial and connective tissue disorders	MESH:D003240
6386793	101	120	depressive disorder	MESH:D003866
6386793	354	372	depressive illness	OMIM:309200
6386793	631	634	CNS	MESH:D002493
6386793	639	661	cardiovascular effects	MESH:D002318
6387529	64	78	panic disorder	MESH:D016584
6387529	329	344	panic disorders	MESH:D016584
6692345	300	318	bladder carcinomas	MESH:D001745
6692345	350	368	forestomach tumors	MESH:D009369
6773726	65	85	autonomic neuropathy	MESH:D003929
6773726	195	212	diabetic subjects	MESH:D014717
6773726	221	241	autonomic neuropathy	MESH:D003929
6773726	249	266	diabetic subjects	MESH:D014717
6773726	272	292	autonomic neuropathy	MESH:D003929
6773726	449	466	diabetic subjects	MESH:D014717
6773726	475	495	autonomic neuropathy	MESH:D003929
6773726	603	620	diabetic subjects	MESH:D014717
6773726	626	646	autonomic neuropathy	MESH:D003929
6773726	788	808	autonomic neuropathy	MESH:D003929
6888657	37	60	adenohypophyseal tumors	MESH:D010900
6888657	85	101	Pituitary tumors	MESH:D010911
6888657	680	694	Ficoll-Hypaque
6888657	1141	1144	DES	OMIM:224050
6888657	1452	1455	DES	OMIM:224050
6888657	1608	1613	tumor	MESH:D009369
6888657	1638	1641	PRL	MESH:D015175
7265370	80	95	nephrolithiasis	MESH:D053040
7265370	333	348	nephrolithiasis	MESH:D053040
7423039	25	50	adriamycin cardiotoxicity
7444978	336	344	deafness	MESH:D003638
7444978	659	670	dyskinesias	MESH:D020820
7834920	0	40	Crescentic fibrillary glomerulonephritis	MESH:D005921
7834920	91	113	pulmonary tuberculosis	MESH:D014397
7834920	183	212	crescentic glomerulonephritis	MESH:D005921
7834920	386	408	pulmonary tuberculosis	MESH:D014397
7834920	462	475	renal failure	MESH:D051437
7834920	545	563	glomerulonephritis	MESH:D005921
7834920	580	613	electron dense fibrillar deposits	MESH:D015432
7834920	709	727	glomerulonephritis	MESH:D005921
7834920	829	847	glomerulonephritis	MESH:D005921
7834920	853	895	crescents and fibrillar glomerulonephritis	MESH:D005921
7881871	71	82	nephropathy	OMIM:161900
7881871	152	183	acute puromycin aminonucleoside	MESH:D000208
7881871	198	209	nephropathy	OMIM:161900
7881871	340	351	proteinuria	MESH:D011507
7881871	857	868	Proteinuria	MESH:D011507
7881871	1127	1142	PAN nephropathy	OMIM:161900
7988234	221	244	coronary artery disease	MESH:D003324
7988234	259	318	myocardial infarctions, hypertension, and diabetes mellitus	MESH:D009203
7988234	333	343	angioedema	MESH:D000799
7988234	647	657	angioedema	MESH:D000799
7988234	663	673	angioedema	MESH:D000799
8073369	76	92	Conium maculatum
8073369	168	187	teratogenic outcome	MESH:C535542
8073369	191	205	arthrogryposis	MESH:D001176
8073369	293	307	arthrogryposis	MESH:D001176
8073369	1607	1621	arthrogryposis	MESH:D001176
8410052	656	677	borderzone of lesions	MESH:D001768
8410052	955	971	ischemic lesions	MESH:D001768
8423889	104	123	Parkinson's disease	MESH:D010300
8682684	202	227	cardiovascular toxicities	MESH:D056486
8682684	309	320	anaphylaxis	MESH:D000707
9625142	0	15	Acute hepatitis	MESH:D017114
9625142	17	44	autoimmune hemolytic anemia	MESH:D000744
9625142	50	72	erythroblastocytopenia
9625142	124	139	acute hepatitis	MESH:D017114
9625142	390	417	autoimmune hemolytic anemia	MESH:D000744
9625142	422	444	erythroblastocytopenia
9766615	593	596	EPS	MESH:C538012
9766615	599	617	tardive dyskinesia	MESH:D009069
9766615	692	707	cardiac effects	MESH:D007088
9766615	709	749	orthostatic hypotension, hepatic changes	MESH:D007024
9766615	781	799	sexual dysfunction	MESH:D012735
9766615	568	591	extrapyramidal symptoms	MESH:D001480
9766615	865	868	EPS	MESH:C538012
9766615	913	921	sedation
9766615	985	1003	sexual dysfunction	MESH:D012735
10193204	57	67	thrombosis	MESH:D013927
10193204	323	333	thrombosis	MESH:D013927
10193204	511	514	FAN
10193204	841	844	TET
10193204	1064	1085	antithrombosis of TET
10193204	1090	1093	FAN
10526274	41	60	cell lung carcinoma	MESH:D055752
10526274	200	228	nonsmall cell lung carcinoma	MESH:D055752
10526274	230	235	NSCLC
10526274	674	677	VNB
10526274	1916	1932	thrombocytopenia	MESH:D013921
10526274	2008	2019	neutropenia	MESH:D009503
10526274	2244	2247	VNB
11379838	344	360	bipolar disorder	MESH:D001714
11379838	679	689	bipolar II	MESH:D001714
11379838	1032	1043	hyperthymia
11379838	1131	1140	hypomania
11379838	1144	1149	mania	MESH:D001714
11379838	1327	1336	hypomanic
11379838	1368	1377	bipolar I	MESH:D001714
11379838	1858	1869	hyperthymia
11419773	17	35	cardiac arrhythmia	MESH:D001145
11419773	170	206	intractable ventricular fibrillation	MESH:D014693
11581460	593	604	bradycardia	MESH:D001919
11581460	660	690	renal pelvocalyceal dilatation	MESH:D002311
11581460	701	715	hydronephrosis	MESH:D006869
11706060	39	53	cardiomyopathy	MESH:D009202
11706060	169	183	cardiomyopathy	MESH:D009202
11706060	185	187	CM
11706060	228	232	AIDS	MESH:D000163
11706060	255	280	mitochondrial dysfunction	OMIM:605711
11706060	1217	1233	cardiac myocytes	MESH:D006331
11706060	1381	1384	ANF
11752354	36	57	myocardial infarction	MESH:D009203
11752354	141	162	myocardial infarction	MESH:D009203
11752354	717	738	myocardial infarction	MESH:D009203
11752354	892	911	cardiovascular risk	MESH:D002318
11752354	1077	1098	myocardial infarction	MESH:D009203
11752354	1747	1768	myocardial infarction	MESH:D009203
11752354	2056	2077	myocardial infarction	MESH:D009203
12369736	365	376	Wistar rats	MESH:D011906
12639165	20	41	cholestatic hepatitis	MESH:D041781
12639165	95	116	cholestatic hepatitis	MESH:D041781
12639165	275	296	cholestatic hepatitis	MESH:D041781
12639165	348	368	coronary angioplasty	MESH:D003327
12639165	570	591	Cholestatic hepatitis	MESH:D041781
12639165	849	870	cholestatic hepatitis	MESH:D041781
12639165	922	931	Hepatitis	MESH:D006505
12639165	1237	1248	cholestasis	MESH:D002779
12639165	1399	1420	Cholestatic hepatitis	MESH:D041781
12653683	116	134	nephrotic syndrome	MESH:D009404
12653683	152	170	nephrotic syndrome	MESH:D009404
12653683	549	567	nephrotic syndrome	MESH:D009404
12653683	652	663	proteinuria	MESH:D011507
12653683	1011	1022	proteinuria	MESH:D011507
12653683	1735	1753	nephrotic syndrome	MESH:D009404
14659530	1118	1145	migraine headache intensity	MESH:D008881
15804801	335	351	stent thrombosis	MESH:D013927
16160878	209	237	hypertension and bradycardia	MESH:D001919
16160878	1670	1691	psychiatric disorders	MESH:D005329
16274958	0	19	Recurrent dysphonia	MESH:D055154
16274958	271	298	acitretin-induced dysphonia	MESH:D055154
16330766	315	337	secondary hyperalgesia	MESH:D006930
16330766	340	362	Secondary hyperalgesia	MESH:D006930
16330766	400	423	neurogenic hyperalgesia	MESH:D006930
16330766	441	452	neuropathic	MESH:D009437
16330766	542	554	hyperalgesia	MESH:D006930
16330766	711	722	neuropathic	MESH:D009437
16330766	1052	1074	secondary hyperalgesia	MESH:D006930
16574712	160	175	memory deficits	MESH:D008569
16574712	1028	1047	latter two deficits	MESH:D058529
17111419	301	315	hyperlipidemia	MESH:D006949
17111419	544	593	acute onset of severe facial and extremity tetany	MESH:D013746
17111419	869	890	systemic hypocalcemia	MESH:D006996
17111419	1007	1019	hypocalcemia	MESH:D006996
17111419	1114	1126	hypocalcemia	MESH:D006996
17175308	351	403	displayed increased proteinuria after SRL conversion	MESH:D011507
17175308	460	463	SRL
17175308	494	523	chronic allograft nephropathy	OMIM:161900
17175308	567	593	sarcoma, Four skin cancers	MESH:D012878
17175308	595	616	One intestinal tumors	MESH:D007410
17175308	525	528	CAN	OMIM:612247
17175308	1030	1041	proteinuria	MESH:D011507
17175308	1357	1371	glomerulopathy	MESH:D015433
17175308	1376	1398	interstitial nephritis	MESH:D009395
17175308	1685	1709	CAN and Kaposi's sarcoma	MESH:D012514
17175308	1951	1968	Heavy proteinuria	MESH:D011507
17175308	2134	2153	CAN and proteinuria	OMIM:612247
17244258	99	107	cystitis	MESH:D003556
17244258	148	156	cystitis	MESH:D003556
17244258	323	331	cystitis	MESH:D003556
17244258	1969	1977	cystitis	MESH:D003556
18020536	1087	1090	BZD
18020536	1091	1093	RD
18020536	1291	1294	BZD
18020536	1295	1297	RD
18020536	1568	1576	dementia	MESH:D003704
18020536	2298	2301	BZD
18020536	2302	2304	RD
18023325	60	87	Acute peripheral neuropathy	MESH:D010523
18023325	289	301	sensory loss	MESH:D016388
18023325	632	641	giddiness
18023325	701	720	sensory dysfunction	MESH:D012678
18023325	814	848	sensorimotor axonal polyneuropathy	MESH:C536446
18023325	1189	1229	acute sensorimotor axonal polyneuropathy	MESH:C536446
18208574	52	62	thrombosis	MESH:D013927
18208574	96	112	thrombocytopenia	MESH:D013921
18208574	208	224	thrombocytopenia	MESH:D013921
18208574	226	229	HIT
18208574	250	260	thrombosis	MESH:D013927
18208574	430	446	thrombocytopenia	MESH:D013921
18208574	551	553	OD	OMIM:165800
18208574	533	549	[optical density	MESH:D009901
18208574	664	667	HIT
18208574	681	691	thrombosis	MESH:D013927
18208574	716	728	isolated-HIT	MESH:C536289
18208574	737	747	thrombosis	MESH:D013927
18208574	762	774	isolated-HIT	MESH:C536289
18208574	794	804	thrombosis	MESH:D013927
18208574	860	870	thrombosis	MESH:D013927
18208574	945	948	HIT
18208574	963	973	thrombosis	MESH:D013927
18208574	1012	1014	OD	OMIM:165800
18208574	1061	1071	thrombosis	MESH:D013927
18208574	1107	1119	isolated-HIT	MESH:C536289
18208574	1149	1159	thrombosis	MESH:D013927
18208574	1210	1222	isolated-HIT	MESH:C536289
18208574	1444	1454	thrombosis	MESH:D013927
18208574	1598	1608	thrombosis	MESH:D013927
18208574	1671	1673	OD	OMIM:165800
18208574	1701	1703	OD	OMIM:165800
18208574	1754	1764	thrombosis	MESH:D013927
18343374	47	75	clomiphene-induced ovulation	MESH:D020751
18343374	305	316	infertility	MESH:D007246
18343374	489	491	CC
18343374	737	755	visual disturbance	MESH:D012640
18343374	762	764	CC
18343374	891	893	CC
18343374	934	945	infertility	MESH:D007246
18343374	960	962	CC
18417364	451	455	BOLD
18417364	421	449	blood oxygen level-dependent	MESH:D000860
18442015	34	60	gastric hemorrhagic ulcers	MESH:D013276
18442015	71	91	atherosclerotic rats	MESH:D010302
18442015	133	174	gastric hemorrhage and mucosal ulceration	MESH:D013276
18442015	187	207	atherosclerotic rats	MESH:D010302
18442015	363	384	mucosal microvascular	MESH:D052016
18442015	454	469	atherosclerosis	MESH:D050197
18442015	760	775	atherosclerosis	MESH:D050197
18442015	1230	1250	atherosclerotic rats	MESH:D010302
18442015	1509	1540	gastric hemorrhage and to ulcer	MESH:D013276
18442015	1560	1580	atherosclerotic rats	MESH:D010302
18442015	1587	1604	hemorrhagic ulcer	MESH:D014456
18442015	1737	1762	gastric hemorrhagic ulcer	MESH:D013276
18619688	19	49	autophagic cardiomyocyte death	MESH:D003643
18619688	92	105	heart failure	MESH:D006333
18619688	145	158	heart failure	MESH:D006333
18619688	315	328	heart failure	MESH:D006333
18619688	406	419	heart failure	MESH:D006333
18619688	552	575	Neonatal cardiomyocytes	MESH:D000751
18619688	1273	1292	autophagic vacuoles	MESH:C536522
18619688	1452	1476	Autophagic cardiomyocyte	MESH:C536522
18619688	1530	1543	heart failure	MESH:D006333
18619688	1575	1595	Mitochondrial injury	MESH:D028361
18619688	1634	1647	heart failure	MESH:D006333
19631624	13	28	memory deficits	MESH:D008569
19631624	921	948	frontocortical hypoactivity	MESH:D001039
19631624	952	960	cannabis	MESH:D002189
19631624	1196	1209	hyperactivity	MESH:D006948
19631624	1385	1461	dorsal anterior cingulated cortex (ACC) and left posterior cingulated cortex	MESH:D000303
19631624	1593	1614	left dorsal cingulate	MESH:D017034
19631624	1665	1689	ecstasy-related deficits	MESH:D009461
20003049	117	133	thrombocytopenia	MESH:D013921
20003049	139	149	thrombosis	MESH:D013927
20003049	277	309	heparin-induced thrombocytopenia	MESH:D013921
20003049	311	314	HIT
20003049	319	322	HIT
20003049	328	338	thrombosis	MESH:D013927
20003049	381	384	CPB
20003049	357	379	cardiopulmonary bypass	MESH:D006323
20003049	1819	1822	CPB
20003049	1836	1848	coagulopathy	MESH:D004211
20196116	33	52	acute liver failure	MESH:D017114
20196116	214	217	ALF
20196116	447	450	ALF
20196116	545	548	ATT
20196116	553	591	simultaneous hepatitis virus infection	MESH:D014412
20196116	679	691	tuberculosis	MESH:D014376
20196116	693	700	ATT-ALF
20196116	790	800	hyperacute
20196116	834	848	encephalopathy	MESH:D001925
20196116	955	978	advanced encephalopathy	MESH:D020178
20196116	983	997	cerebral edema	MESH:D001929
20196116	1111	1130	acute renal failure	MESH:D058186
20196116	1242	1251	hepatitis	MESH:D006505
20196116	1261	1264	HEV
20196116	1290	1293	ALF
20196116	1295	1302	ATT-ALF
20196116	1715	1732	IV encephalopathy	MESH:D001925
20196116	1790	1793	ALF
20470218	57	85	acute lymphoblastic leukemia	MESH:D054198
20470218	194	222	acute lymphoblastic leukemia	MESH:D054198
20470218	224	227	ALL	MESH:D054198
20470218	614	617	CNS	MESH:D002493
20470218	681	691	neuropathy	MESH:D003929
20470218	704	718	encephalopathy	MESH:D001925
20470218	967	986	leukoencephalopathy	MESH:D056784
20722491	163	175	solid tumors	MESH:D059327
20722491	187	231	colorectal, breast and head and neck cancers	MESH:D006258
20722491	361	369	emphasis
20722491	539	563	renal and kidney disease	MESH:D007674
20722491	953	998	gastric, renal cell and head and neck cancers	MESH:D006258
20722491	1089	1099	stomatitis	MESH:D013280
20722491	1104	1122	hand-foot syndrome	MESH:D060831
20722491	1242	1260	renal dysfunctions	MESH:C535382
322550	147	151	CPAP
322550	156	179	cardiovascular dynamics	MESH:D002318
322550	201	203	QS
322550	110	145	continuous positive airway pressure	MESH:D014202
322550	517	545	systemic vascular resistance	MESH:D057772
322550	550	552	QS
322550	730	732	QS
322550	811	839	systemic vascular resistance	MESH:D057772
322550	1090	1092	QS
322550	1322	1345	cardiovascular dynamics	MESH:D002318
869641	371	401	DL-Threo-dihydroxyphenylserine	MESH:C537113
869641	572	583	bradycardia	MESH:D001919
1749407	16	37	myocardial infarction	MESH:D009203
1749407	210	237	acute myocardial infarction	MESH:D009203
1749407	312	339	acute myocardial infarction	MESH:D009203
1786266	0	15	Rabbit syndrome	MESH:D013577
1786266	435	452	movement disorder	MESH:D009069
1919871	76	87	nephropathy	OMIM:161900
1919871	102	126	Renal papillary necrosis	MESH:D007681
1919871	128	131	RPN
1987816	862	870	polyuria	MESH:D011141
2054792	62	67	tumor	MESH:D009369
2054792	111	140	Adriamycin-mediated antitumor	MESH:D006969
2054792	188	205	body hyperthermia	MESH:D005334
2054792	244	253	Antitumor
2054792	283	288	tumor	MESH:D009369
2054792	347	357	leukopenia	MESH:D007970
2054792	362	378	thrombocytopenia	MESH:D013921
2054792	421	449	myocardial and kidney injury	MESH:D058186
2054792	534	557	Whole body hyperthermia	MESH:D005334
2054792	600	629	Adriamycin-mediated antitumor	MESH:D006969
2054792	708	717	antitumor
2054792	895	908	renal lesions	MESH:D001768
2054792	983	1012	Adriamycin-mediated antitumor	MESH:D006969
2312209	0	21	Myocardial infarction	MESH:D009203
2312209	146	167	myocardial infarction	MESH:D009203
2312209	374	393	myocardial ischemia	MESH:D017202
2312209	483	511	acute coronary insufficiency	MESH:D054058
2549018	19	28	akathisia	MESH:D011595
2549018	135	154	compulsive disorder	MESH:D003193
2549018	185	194	akathisia	MESH:D011595
2549018	527	536	akathisia	MESH:D011595
2549018	799	808	akathisia	MESH:D011595
2611118	0	24	Chronic active hepatitis	MESH:D006521
2611118	316	325	hepatitis	MESH:D006505
2611118	381	405	chronic active hepatitis	MESH:D006521
2673163	333	355	Intracranial aneurysms	MESH:D002532
2673163	461	480	cerebral vasculitis	MESH:D020293
2673163	922	944	intracranial aneurysms	MESH:D002532
3107448	18	27	hepatitis	MESH:D006505
3107448	246	271	type II diabetes mellitus	MESH:D003924
3107448	285	314	acute hepatitis-like syndrome	MESH:D017114
3107448	394	409	viral infection	MESH:D015828
3107448	494	503	hepatitis	MESH:D006505
3107448	652	680	acute hepatitis-like illness	MESH:D002908
3341566	602	630	systemic vascular resistance	MESH:D057772
3341566	966	969	HEM	MESH:C535858
3341566	1430	1450	absolute hypovolemia	MESH:D020896
3564823	13	27	arterial spasm	MESH:D020301
3564823	178	196	cerebral ischaemia	MESH:D002543
3676049	371	395	subarachnoid haemorrhage	MESH:D013345
3719553	81	100	angioneurotic edema	MESH:D000799
3719553	186	214	carcinoma of the oral cavity	MESH:D020139
3719553	216	225	cirrhosis	MESH:D005355
3719553	249	272	impaired renal function	OMIM:608852
4008111	19	35	sinoatrial block	MESH:D012848
4008111	49	65	sinoatrial block	MESH:D012848
4008111	132	154	primary cardiomyopathy	MESH:D009202
4008111	156	186	Wolff-Parkinson-White syndrome	MESH:D014927
4008111	191	219	supraventricular tachycardia	MESH:D013617
4008111	349	366	sinus bradycardia	OMIM:608567
6133211	83	109	inflammatory bowel disease	MESH:D015212
6133211	200	220	congenital anomalies	MESH:D009421
6133211	265	283	ulcerative colitis	MESH:D003093
6133211	344	369	ventricular septal defect	MESH:D006345
6133211	409	424	Crohn's disease	MESH:D003424
6133211	458	496	left Potter-type IIa polycystic kidney	MESH:D007690
6133211	598	631	hypoplastic lungs, absent kidneys	MESH:C536903
6503301	0	28	Veno-occlusive liver disease	MESH:D011668
6503301	66	74	melanoma	MESH:D008545
6503301	178	186	melanoma	MESH:D008545
6503301	416	442	Eosinophilic infiltrations	MESH:C535944
6727060	10	28	tardive dyskinesia	MESH:D009069
6727060	197	222	gastrointestinal disorder	MESH:D005767
6727060	507	525	tardive dyskinesia	MESH:D009069
7083920	179	197	atrial tachycardia	MESH:D013612
7083920	225	266	intraventricular conduction abnormalities	MESH:C535853
7083920	300	318	atrial tachycardia	MESH:D013612
7083920	370	372	BH
7083920	500	514	atrial flutter	MESH:D001282
7083920	662	697	intraventricular conduction defects	MESH:C535853
7269015	17	37	hemorrhagic cystitis	MESH:D003556
7269015	68	87	hemorrhage cystitis	MESH:D003556
7269015	219	236	busulfan cystitis	MESH:D003556
7269015	285	293	cystitis	MESH:D003556
7269015	394	409	cellular atypia	MESH:D004806
7269015	414	423	carcinoma	MESH:D002277
7504976	0	15	Toxic hepatitis	MESH:D056486
7504976	329	344	hyperthyroidism	MESH:D006980
7504976	464	479	toxic hepatitis	MESH:D056486
7504976	569	590	cholestatic hepatitis	MESH:D041781
7504976	768	787	cytolytic hepatitis	MESH:D006505
7504976	886	895	hepatitis	MESH:D006505
7504976	1098	1109	neutropenia	MESH:D009503
7504976	1123	1138	Toxic hepatitis	MESH:D056486
7504976	1213	1240	haematological disturbances	MESH:D014832
7628595	308	336	human immunodeficiency virus	MESH:D015658
7628595	338	341	HIV	MESH:D015658
7628595	1098	1125	Severe hematologic toxicity	MESH:D056486
7858459	265	287	gastric adenocarcinoma	MESH:D000230
7858459	331	347	mental confusion	MESH:D003221
7858459	933	986	deficiency, or dihydrouracil dehydrogenase deficiency	MESH:C536257
7858459	1085	1100	various cancers	MESH:D009369
7919560	24	52	hypersensitivity myocarditis	MESH:D009205
7919560	106	114	erythema	MESH:D004890
7919560	130	158	hypersensitivity myocarditis	MESH:D009205
7919560	277	287	septicemia	MESH:D018805
7919560	348	372	congestive heart failure	MESH:D006333
7919560	383	394	myocarditis	MESH:D009205
7919560	592	600	erythema	MESH:D004890
7919560	616	627	myocarditis	MESH:D009205
7919560	701	704	MIF
7919560	803	831	Hypersensitivity myocarditis	MESH:D009205
8092427	602	604	AX
8092427	627	633	AX-PLL
8092427	677	680	BPO
8092427	778	780	PG
8092427	1035	1044	urticaria	MESH:D014581
8092427	1052	1062	angioedema	MESH:D000799
8092427	1150	1153	MDM	MESH:D007645
8092427	1197	1199	AX
8092427	1349	1351	AX
8092427	1395	1397	AX
8092427	1549	1551	AX
8092427	1642	1653	AX-allergic	MESH:D011695
8638206	506	531	renal or hepatic function	OMIM:608852
8638206	751	766	corticosteroids	OMIM:611489
8669433	59	72	renal failure	MESH:D051437
8669433	241	290	chronic renal failure and end-stage renal disease	MESH:D007676
8669433	292	296	ESRD	MESH:D007676
8669433	630	651	chronic renal failure	MESH:D007676
8690168	127	147	diabetic nephropathy	MESH:D003928
8690168	1158	1171	Diabetic rats	MESH:D011906
8690168	1196	1207	albuminuria	MESH:D000419
8739323	61	75	renal toxicity	MESH:D056486
8739323	273	276	CMF
8739323	311	322	Wistar rats	MESH:D011906
8739323	470	511	Histopathologic evaluation of the kidneys	MESH:D007674
8739323	985	988	CMF
8739323	1175	1195	hemorrhagic cystitis	MESH:D003556
8739323	1279	1282	MTX
8752018	204	220	bipolar disorder	MESH:D001714
8752018	329	337	polyuria	MESH:D011141
8752018	391	409	cognitive deficits	MESH:D003072
8752018	849	866	creative deficits	MESH:D009461
8752018	1043	1061	cognitive deficits	MESH:D003072
9390208	32	56	metastatic breast cancer	MESH:D001943
9390208	228	250	advanced breast cancer	MESH:D001943
9390208	568	581	breast cancer	MESH:D001943
9390208	909	922	anthracycline
9390208	1044	1047	MFL
9390208	1234	1253	progressive disease	MESH:D018450
9390208	1492	1522	toxicities were cardiotoxicity	MESH:D056486
9390208	1527	1537	leukopenia	MESH:D007970
9390208	1771	1784	breast cancer	MESH:D001943
9390208	1847	1870	impaired heart function	MESH:D029593
9406968	119	137	diabetes insipidus	MESH:D003919
9406968	301	309	polyuria	MESH:D011141
9406968	385	396	Wistar rats	MESH:D011906
9406968	476	484	polyuria	MESH:D011141
9406968	533	548	hypotonic urine	MESH:D014555
9406968	772	775	SON
9406968	1072	1090	diabetes insipidus	MESH:D003919
9587734	22	36	cardiac arrest	MESH:D006323
9587734	173	186	hyperkalaemia
9587734	300	310	meningitis	MESH:D008581
9587734	435	446	bradycardia	MESH:D001919
9587734	451	465	cardiac arrest	MESH:D006323
9587734	764	777	hyperkalaemia
9698967	122	141	atrial fibrillation	MESH:D001281
9698967	655	674	atrial fibrillation	MESH:D001281
9855119	804	819	IgA nephropathy	MESH:D005922
9855119	873	890	FK506 nephropathy	OMIM:161900
9855119	920	931	nephropathy	OMIM:161900
9855119	1035	1046	nephropathy	OMIM:161900
9855119	1070	1087	FK506 nephropathy	OMIM:161900
9855119	1111	1138	foamy tubular vacuolization	MESH:C535584
9855119	1153	1167	arteriolopathy
9855119	1169	1186	angiodegeneration
9855119	1231	1259	segmental glomerulosclerosis	MESH:C538457
9855119	1405	1416	nephropathy	OMIM:161900
9855119	1524	1541	FK506-nephropathy	OMIM:161900
9855119	1610	1627	FK506 nephropathy	OMIM:161900
9855119	1650	1664	arteriolopathy
9855119	1680	1724	insudative hyalinosis of the arteriolar wall	MESH:D057770
9855119	1762	1779	FK506 nephropathy	OMIM:161900
10342929	0	10	Angioedema	MESH:D000799
10342929	96	106	angioedema	MESH:D000799
10457883	265	276	bradycardia	MESH:D001919
10739826	66	81	thromboembolism	MESH:D013923
10739826	144	159	thromboembolism	MESH:D013923
10739826	502	505	VTE
10791295	85	103	female Wistar rats	MESH:D011906
10791295	210	228	female Wistar rats	MESH:D011906
11198499	124	144	chronic hypertension	MESH:D006973
11198499	278	317	disorders of the central nervous system	MESH:D002493
11198499	1005	1031	hypertension or spasticity	MESH:D006973
11391224	57	93	allografts and native kidney disease	MESH:C538343
11391224	218	232	glomerulopathy	MESH:D015433
11391224	667	685	glomerulonephritis	MESH:D005921
11391224	687	716	chronic allograft nephropathy	OMIM:161900
11391224	844	870	thrombotic microangiopathy	MESH:D057049
11391224	872	894	malignant hypertension	MESH:D006974
11391224	896	924	acute interstitial nephritis	MESH:D009395
11391224	930	952	acute tubular necrosis	MESH:D007683
11391224	1123	1145	malignant hypertension	MESH:D006974
11391224	1147	1173	thrombotic microangiopathy	MESH:D057049
11391224	1175	1190	lupus nephritis	MESH:D008181
11391224	1192	1218	Henoch-Schonlein nephritis	MESH:D011695
11391224	1220	1249	crescentic glomerulonephritis	MESH:D005921
11391224	1271	1290	acute renal failure	MESH:D058186
11391224	1343	1356	renal failure	MESH:D051437
11391224	1666	1696	certain native kidney diseases	MESH:C538343
11391224	1809	1827	immunologic injury	MESH:D007154
11569530	206	229	ventricular tachycardia	MESH:D017180
11569530	475	478	TDP	MESH:D057177
11569530	592	595	TDP	MESH:D057177
11587867	6	25	myeloencephalopathy
11587867	138	185	accidental intrathecal vincristine instillation	MESH:D007035
11587867	222	250	acute lymphoblastic leucemia	MESH:D054198
11587867	278	300	lymphoblastic lymphoma	MESH:D054198
11587867	473	490	motor dysfunction	MESH:C536988
11587867	608	630	degeneration of myelin	MESH:D009410
11679859	1045	1070	restlessness or agitation	MESH:D011595
12041669	67	82	aplastic anemia	MESH:D000741
12041669	142	157	aplastic anemia	MESH:D000741
12041669	511	526	aplastic anemia	MESH:D000741
12198388	1338	1341	WSR
12198388	1349	1352	WSP
12198388	1599	1602	WSP
12198388	1811	1814	WSR
12198388	1929	1952	cholinergic convulsants	MESH:D012640
12198388	2078	2081	WSP
12574103	0	44	Prenatal dexamethasone programs hypertension	MESH:D049188
12574103	49	61	renal injury	MESH:D058186
12574103	308	320	renal injury	MESH:D058186
12574103	1295	1313	glomerulosclerosis	MESH:D003928
12574103	1431	1449	glomerulosclerosis	MESH:D003928
12615818	344	369	polycystic ovary syndrome	MESH:D011085
12615818	371	375	PCOS	MESH:D011085
12615818	441	456	thromboembolism	MESH:D013923
12615818	479	482	CPA
12615818	884	887	CPA
12615818	1127	1146	menopausal symptoms	MESH:D008594
12615818	1203	1205	OR	MESH:D004421
12789195	77	95	endocrine disorder	MESH:D004700
12789195	263	281	tissue hypertrophy	MESH:D006984
12820454	35	41	anemia	MESH:D000740
12820454	45	60	prostate cancer	MESH:D011471
12820454	186	192	anemia	MESH:D000740
12820454	196	211	prostate cancer	MESH:D011471
12820454	307	331	prostatic adenocarcinoma	MESH:D000230
12820454	572	578	anemia	MESH:D000740
12820454	708	733	Testosterone measurements
12820454	1193	1199	anemia	MESH:D000740
12820454	1292	1298	anemia	MESH:D000740
12820454	1377	1383	anemia	MESH:D000740
12820454	1473	1479	anemia	MESH:D000740
12820454	1554	1560	anemia	MESH:D000740
12820454	1730	1736	anemia	MESH:D000740
12820454	1740	1755	prostate cancer	MESH:D011471
12820454	1963	1969	anemia	MESH:D000740
12820454	2160	2166	anemia	MESH:D000740
12820454	2186	2201	prostate cancer	MESH:D011471
14657095	11	33	dilated cardiomyopathy	MESH:D002311
14657095	105	127	dilated cardiomyopathy	MESH:D002311
14657095	235	253	coccidioidomycosis	MESH:D003047
14657095	259	308	echocardiographic abnormalities and heart failure	MESH:D006330
15036754	54	79	neuropathological damages	MESH:D001925
15036754	917	943	cholinolytic drug atropine	MESH:D019966
15036754	1247	1259	DFP-atropine
15036754	1364	1376	DFP-atropine
15145918	1521	1544	rilmenidine hypotension	MESH:D007022
15233872	74	95	myocardial infarction	MESH:D009203
15233872	346	367	myocardial infarction	MESH:D009203
15233872	929	932	TCR
15458908	377	389	osteoporosis	MESH:D010024
15458908	484	506	venous thromboembolism	MESH:D054556
15458908	508	517	cataracts	MESH:D002386
15458908	519	538	gallbladder disease	MESH:D005705
15458908	544	567	endometrial hyperplasia	MESH:D004714
15458908	571	577	cancer	MESH:D009369
15458908	679	701	venous thromboembolism	MESH:D054556
15458908	1125	1134	cataracts	MESH:D002386
15458908	1161	1180	gallbladder disease	MESH:D005705
15458908	1207	1230	endometrial hyperplasia	MESH:D004714
15458908	1260	1278	endometrial cancer	MESH:D016889
15458908	1377	1392	thromboembolism	MESH:D013923
15458908	1430	1439	cataracts	MESH:D002386
15458908	1441	1460	gallbladder disease	MESH:D005705
15458908	1462	1485	endometrial hyperplasia	MESH:D004714
15458908	1490	1508	endometrial cancer	MESH:D016889
15737522	123	138	pseudolithiasis
15737522	228	251	gallbladder dysfunction	MESH:D005705
15737522	309	324	pseudolithiasis
16005948	140	148	epidemic	MESH:D004671
16167916	430	440	osteopenia	MESH:D001851
16167916	444	456	osteoporosis	MESH:D010024
16167916	1372	1394	venous thromboembolism	MESH:D054556
16403073	223	246	coronary artery disease	MESH:D003324
16403073	367	383	fungal infection	MESH:D008172
16403073	766	791	acquired long QT syndrome	MESH:D008133
16755009	81	103	cognitive dysfunctions	MESH:D003072
16904497	0	21	Cauda equina syndrome	MESH:D011128
16904497	28	54	epidural steroid injection	MESH:D015174
16904497	116	141	lumbusacral radiculopathy	MESH:D011843
16904497	244	265	Cauda equina syndrome	MESH:D011128
16904497	347	368	cauda equina syndrome	MESH:D011128
16904497	966	983	perineal numbness	MESH:D006987
16904497	988	1003	lower extremity	MESH:D010264
16904497	1616	1640	neurologic deterioration	MESH:C536671
16938416	42	57	atherosclerosis	MESH:D050197
16938416	151	166	atherosclerosis	MESH:D050197
16938416	444	466	aortic atherosclerosis	MESH:D050197
16938416	468	490	Aortic atherosclerosis	MESH:D050197
16938416	610	632	intima atherosclerosis	MESH:D050197
16938416	815	830	atherosclerosis	MESH:D050197
16938416	906	921	atherosclerosis	MESH:D050197
16938416	1337	1352	atherosclerosis	MESH:D050197
17147461	37	54	renal dysfunction	MESH:C535382
17147461	346	367	allograft nephropathy	OMIM:161900
17147461	396	414	glomerulonephritis	MESH:D005921
17147461	416	451	autoimmunity, cystic renal diseases	MESH:D052177
17147461	456	468	renal cancer	MESH:D007680
17147461	743	754	proteinuria	MESH:D011507
17147461	759	782	acute renal dysfunction	MESH:D058186
17147461	852	864	renal damage	MESH:D001925
17147461	1212	1229	renal dysfunction	MESH:C535382
17147461	1640	1654	renal function	OMIM:608852
17241784	12	20	myopathy	MESH:D009135
17241784	113	121	myopathy	MESH:D009135
17241784	126	138	hyperCKaemia
17241784	254	262	myopathy	MESH:D009135
17241784	391	399	necrosis	MESH:D009336
17241784	735	759	immune-mediated myopathy	MESH:D007154
17241784	868	876	myopathy	MESH:D009135
17261653	140	164	cardiac sympathetic tone	MESH:D006732
17261653	215	237	cardiovascular disease	MESH:D002318
17261653	249	259	arrhythmia	MESH:D001145
17261653	261	283	coronary heart disease	MESH:D003327
17261653	289	310	chronic heart failure	MESH:D006333
17261653	957	986	Clonidine-induced bradycardia	MESH:D001919
17261653	1315	1340	sinoatrial node pacemaker	MESH:D012848
17261653	1726	1729	HCN
17343925	370	382	hearing loss	MESH:D034381
17343925	589	630	neonatal screening for hearing impairment	MESH:D034381
17400887	110	116	autism	MESH:D001321
17400887	130	157	neurodevelopmental disorder	MESH:C531680
17400887	196	239	deficits in communication and social skills	MESH:D019957
17400887	281	299	genetic influences	MESH:D020022
17400887	386	392	autism	MESH:D001321
17400887	517	523	autism	MESH:D001321
17400887	1545	1569	behavioral abnormalities	MESH:D001523
17400887	1601	1607	autism	MESH:D001321
17400887	1712	1737	autism spectrum disorders	MESH:D002659
17612891	0	17	Acute myocarditis	MESH:D009205
17612891	66	83	acute myocarditis	MESH:D009205
17612891	346	359	schizophrenia	MESH:D012559
17612891	372	399	sudden onset of myocarditis	MESH:D009205
17612891	967	976	awareness	MESH:D058926
18081909	0	14	Encephalopathy	MESH:D001925
18081909	136	150	encephalopathy	MESH:D001925
18081909	195	214	idiopathic epilepsy	MESH:D004829
18081909	405	431	Neuropsychological testing	MESH:D013736
18083142	105	112	anxiety	MESH:D001008
18083142	656	663	anxiety	MESH:D001008
18083142	967	974	anxiety	MESH:D001008
18083142	1258	1265	anxiety	MESH:D001008
18083142	1539	1546	anxiety	MESH:D001008
18182964	14	54	attention-deficit/hyperactivity disorder	MESH:D001289
18182964	216	256	attention-deficit/hyperactivity disorder	MESH:D001289
18182964	258	262	ADHD	MESH:D001289
18182964	337	341	ADHD	MESH:D001289
18182964	757	768	bradycardia	MESH:D001919
18182964	1453	1457	ADHD	MESH:D001289
18182964	1511	1522	bradycardia	MESH:D001919
18217897	61	102	refractory indolent non-Hodgkin lymphomas	MESH:D008228
18217897	128	147	Cancer and Leukemia	MESH:D009369
18217897	237	244	myeloma	MESH:D009101
18217897	271	297	lymphoplasmacytic lymphoma	MESH:D008223
18217897	352	358	tumour	MESH:D015275
18217897	971	996	myelosuppression, fatigue	MESH:D005221
18217897	1025	1035	neuropathy	MESH:D003929
18217897	1040	1047	dyspnea	MESH:D004417
18217897	1202	1220	indolent lymphomas	MESH:D034721
18996674	276	278	ED	MESH:C536181
18996674	254	274	Emergency Department	MESH:D004630
18996674	382	384	ED	MESH:C536181
18996674	490	528	intracorporal epinephrine instillation
19058010	71	92	myocardial infarction	MESH:D009203
19058010	347	368	myocardial infarction	MESH:D009203
19058010	1292	1313	myocardial infarction	MESH:D009203
19581773	89	106	chronic hepatitis	MESH:D006521
19581773	141	156	sudden diplopia	MESH:D004172
19581773	246	263	chronic hepatitis	MESH:D006521
19581773	267	270	CHC
19581773	886	889	CHC
19759529	334	361	schizophrenic-like symptoms	MESH:D012559
19759529	1020	1033	hyperactivity	MESH:D006948
19759529	1141	1144	DAT
19759529	1486	1489	DAT
19759529	1679	1692	hyperactivity	MESH:D006948
19759529	1883	1909	antipsychotic-like effects	MESH:D007088
19957053	555	558	MAP	MESH:C535477
19957053	531	553	mean arterial pressure	MESH:D003668
19957053	598	600	SV
19957053	583	596	stroke volume	MESH:D020521
19957053	761	775	CO concomitant
20619828	35	70	obsessive-compulsive-like behaviors	MESH:D009771
20619828	120	149	obsessive-compulsive disorder	MESH:D009771
20619828	151	154	OCD	MESH:D009771
20619828	319	322	OCD	MESH:D009771
20619828	857	884	corticostriatal dysfunction	MESH:D013132
20619828	1123	1126	OCD	MESH:D009771
20619828	1271	1274	OCD	MESH:D009771
20619828	1296	1299	OCD	MESH:D009771
20619828	1499	1520	psychiatric disorders	MESH:D005329
891050	52	77	hemolytic uremic syndrome	MESH:D006463
891050	105	130	hemolytic uremic syndrome	MESH:D006463
891050	132	135	HUS	MESH:C531700
891050	223	235	hemodialysis
891050	343	349	anuria	MESH:D001002
891050	351	359	dialysis
891050	425	428	HUS	MESH:C531700
891050	593	596	HUS	MESH:C531700
891050	704	716	hypertension	MESH:D006973
891050	721	754	microangiopathic hemolytic anemia	MESH:D011697
983936	89	106	myocardial injury	MESH:D009202
983936	159	176	myocardial injury	MESH:D009202
983936	315	342	acute myocardial infarction	MESH:D009203
1428568	83	101	sexual dysfunction	MESH:D012735
1428568	354	366	glaucomatous
1720453	23	48	ifosfamide renal toxicity	MESH:D056486
1720453	73	101	malignant mesenchymal tumors	MESH:C535700
1720453	197	225	malignant mesenchymal tumors	MESH:C535700
1720453	743	748	tumor	MESH:D009369
1720453	855	865	glucosuria	MESH:D006030
1720453	867	878	proteinuria	MESH:D011507
1720453	880	893	aminoaciduria	MESH:D000608
1720453	980	997	microglobulinuria
1720453	1097	1116	renal abnormalities	MESH:D002869
1720453	1264	1272	toxicity	MESH:D056486
1720453	1286	1304	Fanconi's syndrome	MESH:D005198
1720453	1306	1310	TDFS
1720453	1378	1395	microglobulinuria
1720453	1477	1494	microglobulinuria
1720453	1650	1671	vesicoprostatic tumor	MESH:D009369
1720453	1713	1717	TDFS
1720453	1799	1817	mesenchymal tumors	MESH:C535700
1833784	90	103	hyperactivity	MESH:D006948
1833784	1217	1230	hyperactivity	MESH:D006948
1867351	212	228	anxiety neurosis	MESH:D001008
1867351	686	702	neuropsychiatric	MESH:D020945
1867351	815	834	malaria prophylaxis	MESH:D008288
2266990	12	42	double-blind trial of mazindol	MESH:C535997
2266990	46	64	Duchenne dystrophy	MESH:D020388
2266990	141	149	weakness	MESH:D018908
2266990	153	171	Duchenne dystrophy	MESH:D020388
2266990	290	308	Duchenne dystrophy	MESH:D020388
2266990	1294	1302	weakness	MESH:D018908
2266990	1306	1324	Duchenne dystrophy	MESH:D020388
2348231	63	81	coronary hyperemia	MESH:D006940
2348231	241	268	peripheral vascular disease	MESH:D016491
2348231	456	474	coronary hyperemia	MESH:D006940
2348231	1109	1118	hyperemia	MESH:D006940
2348231	1285	1303	coronary hyperemia	MESH:D006940
2355241	35	54	Parkinson's disease	MESH:D010300
2355241	215	234	Parkinson's disease	MESH:D010300
2355241	366	375	pneumonia	MESH:D011014
2355241	380	390	bronchitis	MESH:D001991
2355241	400	419	malignant neoplasms	MESH:D001932
2355241	798	817	Parkinson's disease	MESH:D010300
2355241	834	864	hypotensive effect of levodopa	MESH:D007022
2445283	61	88	Argentine hemorrhagic fever	MESH:D006480
2445283	165	192	Argentine hemorrhagic fever	MESH:D006480
2445283	194	197	AHF
2445283	275	300	neutralization of viremia	MESH:D014766
2445283	397	403	anemia	MESH:D000740
2445283	534	537	AHF
2445283	548	554	anemia	MESH:D000740
2950248	21	40	myocardial ischemia	MESH:D017202
2950248	357	376	myocardial ischemia	MESH:D017202
2950248	435	458	coronary artery disease	MESH:D003324
2950248	618	626	ischemia	MESH:D007511
3015567	121	144	glucocorticoid feedback	OMIM:202200
3015567	318	348	hypophysial-portal circulation	MESH:D006975
3015567	627	651	glucocorticoid synthesis	OMIM:202200
3031535	891	900	catalepsy	MESH:D002375
3125768	166	190	arterial, central venous	MESH:D020787
3125768	557	560	CVP
3125768	994	997	ICP	MESH:C535932
3187073	127	159	advanced head and neck carcinoma	MESH:D006258
3187073	164	184	esophageal carcinoma	MESH:D004941
3187073	727	749	cardiovascular disease	MESH:D002318
3187073	944	971	incidence of cardiotoxicity
3187073	1013	1035	cardiovascular disease	MESH:D002318
3187073	1148	1189	ST-T wave changes and atrial fibrillation	MESH:D001281
3187073	1426	1441	tachyarrhythmia	MESH:D013610
3503576	193	199	anemia	MESH:D000740
3503576	1048	1068	auditory abnormality	MESH:C538268
3503576	1865	1877	hearing loss	MESH:D034381
3503576	2195	2215	auditory dysfunction	MESH:D001304
3560095	33	62	juvenile rheumatoid arthritis	MESH:D001171
3560095	90	119	juvenile rheumatoid arthritis	MESH:D001171
3560095	249	258	arthritis	MESH:D001168
3714122	75	86	neuropathic	MESH:D009437
3714122	127	138	neuropathic	MESH:D009437
3714122	164	183	neurotoxic esterase	MESH:D020258
3714122	187	197	neuropathy	MESH:D003929
3714122	1294	1305	neuropathic	MESH:D009437
3828020	0	19	Cerebral infarction	MESH:D002544
3828020	345	370	neuropsychiatric symptoms	MESH:D009461
3828020	376	410	nonhemorrhagic cerebral infarction	MESH:D002544
4812392	125	134	psoriasis	MESH:D011565
6518066	599	620	cardiac malformations	MESH:D006331
6534871	37	71	experimental myocardial infarction	MESH:D009203
6534871	152	173	myocardial infarction	MESH:D009203
6534871	605	616	cardiac GOT	MESH:D006331
6534871	738	759	myocardial infarction	MESH:D009203
6538499	525	533	leukemia	MESH:D007938
6538499	549	562	ascites tumor	MESH:D001201
6747681	50	97	malignant gliomas of the central nervous system	MESH:D005910
6747681	310	327	malignant gliomas	MESH:D005910
6747681	458	474	vertebral artery	MESH:C538664
6747681	618	646	Grade III or IV astrocytomas	MESH:D005909
6747681	691	696	tumor	MESH:D009369
6747681	808	813	tumor	MESH:D009369
6747681	1217	1232	IV astrocytomas	MESH:D001254
6747681	1641	1659	retinal vasculitis	MESH:D031300
6747681	1678	1689	visual loss	MESH:D012640
7053303	768	776	dementia	MESH:D003704
7053303	896	919	liver or kidney disease	MESH:D008107
7053303	1027	1035	dementia	MESH:D003704
7088431	287	296	carcinoma	MESH:D002277
7088431	445	454	carcinoma	MESH:D002277
7088431	525	546	Hysterosalpingography
7248170	109	118	cirrhosis	MESH:D005355
7248170	177	206	shrunken finely nodular liver	MESH:D014202
7248170	334	352	testicular atrophy	MESH:C537489
7453952	35	67	diabetes-insipidus-like syndrome	MESH:D003919
7453952	148	156	polyuria	MESH:D011141
7453952	834	866	diabetes-insipidus-like syndrome	MESH:D003919
7453952	1165	1173	polyuria	MESH:D011141
7802851	76	90	panic disorder	MESH:D016584
7802851	245	259	panic disorder	MESH:D016584
7802851	265	276	agoraphobia	MESH:D000379
7802851	433	447	panic disorder	MESH:D016584
7802851	453	464	agoraphobia	MESH:D000379
7802851	944	950	ataxia	MESH:D001259
8319760	70	79	nephrosis	MESH:D009401
8319760	99	118	nephrotic syndromes	MESH:D009404
8319760	127	138	proteinuria	MESH:D011507
8319760	140	155	hypoalbuminemia	MESH:D034141
8319760	157	177	hypercholesterolemia	MESH:D006937
8319760	552	561	nephrosis	MESH:D009401
8386779	83	103	erectile dysfunction	MESH:D007172
8421099	138	149	acromegalic
8421099	528	547	acute cholecystitis	MESH:D041881
8421099	606	631	gallbladder contractility	MESH:D005705
8421099	724	749	gallbladder contractility	MESH:D005705
8421099	889	921	normal gallbladder contractility	MESH:D005705
8421099	1015	1040	gallbladder contractility	MESH:D005705
8421099	1244	1269	gallbladder contractility	MESH:D005705
8421099	1343	1356	cholecystitis	MESH:D002764
8421099	1394	1405	acromegalic
8649546	32	42	dyskinesia	MESH:D020820
8649546	112	131	Parkinson's disease	MESH:D010300
8649546	133	135	PD	OMIM:168600
8649546	161	171	dyskinesia	MESH:D020820
8649546	386	404	choreic dyskinesia	MESH:D002819
8649546	432	448	whereas dystonia	MESH:D004421
8649546	571	589	choreic dyskinesia	MESH:D002819
8649546	593	595	PD	OMIM:168600
8919272	26	40	encephalopathy	MESH:D001925
8919272	160	196	capillaries in the cerebellar cortex	MESH:D000303
8919272	391	413	neurological disorders	MESH:D009422
8919272	445	469	valproate encephalopathy	MESH:C536525
8919272	2011	2025	hyperammonemia	MESH:D022124
8919272	2051	2075	valproate encephalopathy	MESH:C536525
9199746	123	139	visual prognosis	MESH:D012640
9199746	143	158	endophthalmitis	MESH:D009877
9199746	160	178	macular infarction	MESH:D007238
9199746	347	376	streptococcal endophthalmitis	MESH:D009877
9199746	387	402	Endophthalmitis	MESH:D009877
9199746	530	556	closure and telangiectasis	MESH:D013684
9199746	633	649	retinal toxicity	MESH:D056486
9199746	654	671	macular ischaemia	MESH:D008268
9199746	703	728	avoiding retinal toxicity	MESH:D056486
9249847	35	73	atrioventricular reentrant tachycardia	MESH:D013611
9249847	130	160	Wolff-Parkinson-White syndrome	MESH:D014927
9249847	165	198	idiopathic dilated cardiomyopathy	MESH:C536277
9249847	218	230	WPW syndrome	MESH:D014927
9249847	235	268	idiopathic dilated cardiomyopathy	MESH:C536277
9249847	282	320	atrioventricular reentrant tachycardia	MESH:D013611
9249847	322	326	AVRT
9249847	356	359	QRS	MESH:D008151
9284778	0	25	Epidemic of liver disease	MESH:D008107
9284778	369	394	epidemic of liver disease	MESH:D008107
9284778	618	633	various degrees
9284778	919	932	liver disease	MESH:D008107
9284778	1279	1287	FINDINGS	MESH:D009461
9284778	1433	1470	portal tracts and centrilobular areas	MESH:D011656
9284778	1633	1652	halothane hepatitis	MESH:D006505
9522143	46	58	hearing loss	MESH:D034381
9522143	102	114	hearing loss	MESH:D034381
9522143	265	291	sensorineural hearing loss	MESH:D006319
9522143	336	348	hearing loss	MESH:D034381
9522143	408	420	hearing loss	MESH:D034381
9522143	609	621	hearing loss	MESH:D034381
9522143	848	860	hearing loss	MESH:D034381
9522152	12	32	neurological deficit	MESH:D009461
9522152	161	181	neurological deficit	MESH:D009461
9522152	429	472	area of hypoaesthesia over L3-L4 dermatomes	MESH:D006963
9522152	1135	1155	neurological deficit	MESH:D009461
9672936	518	530	CNS toxicity	MESH:D056486
9721172	52	77	Stevens-Johnson syndromes	MESH:D013262
9721172	106	124	bile duct syndrome	MESH:D001649
9721172	172	183	cholestasis	MESH:D002779
9721172	313	337	Stevens-Johnson syndrome	MESH:D013262
9721172	622	640	bile duct syndrome	MESH:D001649
9721172	825	844	cholestatic disease	MESH:D041781
9721172	867	876	cirrhosis	MESH:D005355
9721172	971	989	bile duct syndrome	MESH:D001649
9721172	1083	1107	Stevens-Johnson syndrome	MESH:D013262
9721172	1122	1140	bile duct syndrome	MESH:D001649
9754849	85	98	hyperkinesias	MESH:D006948
9754849	437	454	EEG abnormalities	MESH:D002869
10365197	0	29	Cocaine-induced mood disorder	MESH:D019964
10365197	287	316	cocaine-induced mood disorder	MESH:D019964
10365197	318	322	CIMD
10365197	331	345	mood disorders	MESH:D019964
10365197	353	366	mood disorder	MESH:D019964
10365197	442	446	CIMD
10365197	508	512	CIMD
10365197	561	581	depressive disorders	MESH:D003866
10365197	597	601	CIMD
10365197	759	763	CIMD
10704919	188	201	breast cancer	MESH:D001943
10704919	263	279	hemolytic anemia	MESH:D000743
10704919	416	432	hemolytic anemia	MESH:D000743
10704919	907	914	alpha-T	MESH:D015458
10704919	889	905	alpha-tocopherol	MESH:D005935
10704919	1204	1213	hemolysis	MESH:D006461
10704919	1699	1706	alpha-T	MESH:D015458
10704919	2357	2373	hemolytic anemia	MESH:D000743
10704919	2514	2517	TAM	OMIM:159595
10706004	83	105	nitric oxide deficient	MESH:D028361
10706004	245	267	sustained hypertension	MESH:D006973
10706004	514	526	NO-deficient	MESH:D002311
10706004	940	952	NO-deficient	MESH:D002311
10706004	1126	1138	NO-deficient	MESH:D002311
10721819	78	89	tachycardia	MESH:D013610
10721819	154	165	tachycardia	MESH:D013610
10721819	542	553	tachycardia	MESH:D013610
10721819	619	638	cardiac hypertrophy	MESH:D006332
10721819	792	803	tachycardia	MESH:D013610
10721819	885	902	while tachycardia	MESH:D013610
10721819	931	942	bradycardia	MESH:D001919
10721819	1553	1564	tachycardia	MESH:D013610
10721819	1568	1579	bradycardia	MESH:D001919
10737864	51	63	cardiac rate	MESH:D006331
10737864	655	667	cardiac rate	MESH:D006331
10737864	1021	1033	cardiac rate	MESH:D006331
10737864	1056	1067	bradycardia	MESH:D001919
10743446	88	107	static hyperalgesia	MESH:D006930
10743446	824	827	VAS	MESH:C535984
10743446	843	888	brush-evoked and punctate-evoked hyperalgesia	MESH:D006930
10743446	1121	1124	VAS	MESH:C535984
10743446	1251	1271	dynamic hyperalgesia	MESH:D006930
10743446	1302	1314	hyperalgesia	MESH:D006930
11007689	50	65	microangiopathy	MESH:D059345
11007689	86	112	thrombotic microangiopathy	MESH:D057049
11007689	114	117	TMA
11256525	19	25	anuria	MESH:D001002
11256525	157	172	solitary kidney	MESH:D001845
11256525	185	204	renal insufficiency	MESH:D051437
11256525	245	251	anuria	MESH:D001002
11256525	309	330	myocardial infarction	MESH:D009203
11256525	401	430	systolic dysfunction losartan	MESH:D054160
11256525	511	524	sudden anuria	MESH:D001002
11256525	746	752	anuria	MESH:D001002
11256525	1096	1099	RAS
11256525	1070	1094	renin-angiotensin system	MESH:D012595
11256525	1388	1408	renovascular disease	MESH:D006978
11334364	108	122	nephrotoxicity
11334364	124	156	amiodarone-induced lung toxicity	MESH:D056486
11334364	565	579	nephrotoxicity
11334364	593	596	AMI
11334364	581	591	amiodarone
11334364	930	933	AAP
11334364	955	958	AMI
11334364	1071	1074	ALT
11334364	1076	1079	BUN
11334364	1042	1069	analysis of serum chemistry	MESH:D012713
11334364	1329	1332	AAP
11334364	1334	1337	AMI
11334364	1342	1345	DOX
11334364	1418	1421	ALT
11334364	1423	1426	BUN
11334364	1960	1963	AMI
11334364	1968	1971	DOX
11334364	2100	2103	AMI
11334364	2108	2111	DOX
12084448	11	25	encephalopathy	MESH:D001925
12084448	143	175	variety of neurological symptoms	MESH:D009461
12084448	280	324	myoclonus of the upper and lower extremities	MESH:D009207
12084448	362	374	plasmacytoma	MESH:D010954
12084448	413	426	mental status	MESH:D013226
12084448	562	621	structural lesions of the brain and metabolic abnormalities	MESH:D001928
12084448	757	771	encephalopathy	MESH:D001925
12684739	401	421	visual field defects	MESH:D012640
12684739	423	426	VFD
12684739	593	595	DA
12684739	583	591	dopamine	MESH:D013580
12684739	1198	1202	VFDS
12716030	23	31	hematoma	MESH:D006406
12716030	325	342	ICH deterioration	MESH:C536671
12716030	564	590	determined hematoma volume	MESH:D003643
12716030	614	622	hematoma	MESH:D006406
12716030	670	678	hematoma	MESH:D006406
12716030	736	753	ICH deterioration	MESH:C536671
12716030	823	831	hematoma	MESH:D006406
12716030	1117	1120	ICH
12905102	1380	1405	inferior clinical outcome	MESH:D056989
14513889	71	94	weakness of extremities	MESH:D020336
14513889	112	122	dysarthria	MESH:D004401
15009014	154	175	vascular dysfunctions	MESH:D014652
15009014	242	264	autonomic dysfunctions	MESH:D020361
15009014	275	320	facial and intracranial vascular disturbances	MESH:D002561
15009014	582	595	facial mucosa	MESH:C536135
15009014	1146	1149	VIP	MESH:D003969
15009014	1111	1144	vasoactive intestinal polypeptide	MESH:D003969
15120741	104	134	systemic pilocarpine injection	MESH:D012595
15275829	111	125	hypolocomotion
15602202	10	38	acute interstitial nephritis	MESH:D009395
15602202	133	161	acute interstitial nephritis	MESH:D009395
15602202	260	282	corticosteroid therapy	MESH:D016609
15602202	284	298	renal function	OMIM:608852
15602202	360	388	acute interstitial nephritis	MESH:D009395
15602202	458	470	renal injury	MESH:D058186
16181582	18	32	encephalopathy	MESH:D001925
16181582	52	66	encephalopathy	MESH:D001925
16181582	280	294	hyperammonemia	MESH:D022124
16181582	410	424	encephalopathy	MESH:D001925
16298782	578	604	sensorineural hearing loss	MESH:D006319
16298782	846	858	hearing loss	MESH:D034381
16298782	959	971	hearing loss	MESH:D034381
16428221	0	19	Cerebral vasculitis	MESH:D020293
16428221	159	178	Cerebral vasculitis	MESH:D020293
16428221	500	519	cerebral vasculitis	MESH:D020293
16428221	668	703	methylphenidate mediated vasculitis	MESH:D014657
16428221	742	763	neurological symptoms	MESH:D009461
17466854	311	319	cataract	MESH:D002386
17466854	349	371	Hospital, Gwardamangia	MESH:D003428
17562951	115	126	nephropathy	OMIM:161900
17562951	144	166	chronic kidney disease	MESH:D007674
17562951	432	468	double-blind comparison of iopamidol	MESH:C535997
17562951	500	522	chronic kidney disease	MESH:D007674
17562951	593	612	cardiac angiography	MESH:D006331
17562951	1104	1121	diabetes mellitus	MESH:D003920
17562951	1967	1978	nephropathy	OMIM:161900
17562951	2147	2164	diabetes mellitus	MESH:D003920
17600377	40	69	attenuates cognitive deficits	MESH:D003072
17600377	544	572	attenuate cognitive deficits	MESH:D003072
17600377	1309	1323	neuronal death	MESH:D003643
17854040	66	83	hepatitis B virus	MESH:D006509
17854040	85	88	HBV	MESH:D006509
17854040	300	317	hepatitis B virus	MESH:D006509
17854040	392	420	human immunodeficiency virus	MESH:D015658
17854040	422	425	HIV	MESH:D015658
17854040	319	322	HBV	MESH:D006509
17854040	497	500	HBV	MESH:D006509
17854040	1329	1348	chronic hepatitis B	MESH:D019694
18261172	161	178	renal dysfunction	MESH:C535382
18261172	641	652	Proteinuria	MESH:D011507
18261172	986	997	proteinuria	MESH:D011507
18261172	1028	1039	proteinuria	MESH:D011507
18261172	1044	1068	increased renal function	OMIM:608852
18261172	1164	1188	decreased renal function	OMIM:608852
18261172	1254	1265	proteinuria	MESH:D011507
18261172	1281	1299	cardiac transplant	MESH:D006331
18261172	1468	1479	proteinuria	MESH:D011507
18261172	1484	1511	increased renal dysfunction	MESH:C535382
18329269	290	293	MED	MESH:C536739
18410508	883	887	METH
18410508	943	945	DA
18503483	34	51	brachial neuritis	MESH:D020968
18503483	349	363	encephalopathy	MESH:D001925
18503483	389	410	neurological deficits	MESH:D009461
18503483	617	625	myelitis	MESH:D009187
18503483	636	653	brachial plexitis	MESH:D020968
18560792	0	22	Valvular heart disease	MESH:D006349
18560792	126	154	Valvular heart abnormalities	MESH:D006349
18560792	191	210	Parkinson's disease	MESH:D010300
18560792	212	214	PD	OMIM:168600
18560792	455	481	valvular heart abnormality	MESH:D006349
18560792	573	575	PD	OMIM:168600
18560792	724	726	PD	OMIM:168600
18560792	911	917	non-PD	OMIM:168600
18560792	1119	1121	PD	OMIM:168600
18560792	1534	1547	heart failure	MESH:D006333
18560792	1596	1618	valvular heart disease	MESH:D006349
18560792	1741	1754	heart failure	MESH:D006333
18560792	1880	1882	PD	OMIM:168600
18726058	218	235	nerve dysfunction	MESH:D018754
18726058	1426	1452	sensorineural hearing loss	MESH:D006319
18726058	1908	1940	potential cranial nerve deficits	MESH:D003389
18754075	8	19	proteinuria	MESH:D011507
18754075	24	43	acute renal failure	MESH:D058186
18754075	123	151	segmental glomerulosclerosis	MESH:C538457
18754075	185	203	nephrotic syndrome	MESH:D009404
18754075	211	245	focal segmental glomerulosclerosis	MESH:D005923
18754075	513	532	acute renal failure	MESH:D058186
18754075	612	624	hemodialysis
18754075	906	925	acute renal failure	MESH:D058186
18768591	68	86	nephrotic syndrome	MESH:D009404
18768591	108	119	nephropathy	OMIM:161900
18768591	193	207	renal fibrosis	MESH:D005355
18768591	355	369	renal fibrosis	MESH:D005355
18768591	505	513	fibrosis	MESH:D005355
18768591	521	539	nephrotic syndrome	MESH:D009404
18768591	852	870	nephrotic syndrome	MESH:D009404
18768591	885	894	lipidemia	MESH:D006949
18768591	900	915	hypoalbuminemia	MESH:D034141
18768591	1392	1410	nephrotic syndrome	MESH:D009404
18768591	1521	1527	uremia	MESH:D014511
18768591	1723	1737	renal fibrosis	MESH:D005355
18768591	1745	1776	experimental nephrotic syndrome	MESH:D009404
19299179	81	93	Pneumocystis	MESH:D016720
19299179	107	119	HIV-infected	MESH:D015658
19299179	153	165	Pneumocystis	MESH:D016720
19299179	177	180	PCP	MESH:D010623
19299179	413	425	HIV-infected	MESH:D015658
19299179	456	480	intrahepatic cholestasis	MESH:D002780
19356053	943	954	proteinuria	MESH:D011507
19356053	996	1021	turbidometric measurement
19356053	1089	1100	proteinuria	MESH:D011507
19356053	1563	1590	nephrotic-range proteinuria	MESH:D011507
19356053	1805	1816	proteinuria	MESH:D011507
19356053	1946	1957	Proteinuria	MESH:D011507
20520283	119	132	schizophrenia	MESH:D012559
20520283	226	239	schizophrenia	MESH:D012559
20520283	286	304	bipolar I disorder	MESH:D001714
20520283	391	410	acute schizophrenia	MESH:D012559
20520283	494	497	BID
20588063	119	144	aminonucleoside nephrosis	MESH:D009401
20588063	219	230	proteinuria	MESH:D011507
20588063	271	280	nephrosis	MESH:D009401
20588063	1357	1368	proteinuria	MESH:D011507
19820426	27	43	cardiac toxicity	MESH:D056486
19820426	182	214	immunodeficiency virus infection	MESH:D014412
19820426	243	263	complete heart block	MESH:C535758
19820426	268	290	dilated cardiomyopathy	MESH:D002311
19820426	403	414	bradycardia	MESH:D001919
567256	0	12	Angiosarcoma	MESH:D006394
567256	62	74	Angiosarcoma	MESH:D006394
567256	231	243	Angiosarcoma	MESH:D006394
567256	323	344	intraarterial lesions	MESH:D001768
567256	373	387	primary tumors	MESH:D001932
17439425	112	117	GC-HT	MESH:D050031
17439425	75	110	Glucocorticoid-induced hypertension	OMIM:202200
17439425	333	339	dex-HT	MESH:D050031
17439425	297	331	dexamethasone-induced hypertension	MESH:D046110
17439425	536	539	SBP
17439425	510	534	Systolic blood pressures	MESH:D007022
17439425	1101	1150	adrenocorticotrophic hormone induced hypertension	MESH:D046110
18752389	30	45	hepatic failure	MESH:D017093
20098969	369	389	cardiac dysrhythmias	MESH:D001145
20098969	519	529	xerostomia	MESH:D014987
20098969	903	918	carious lesions	MESH:D001768
20098969	1631	1651	Dental practitioners	MESH:D009057
9653867	36	50	thyrotoxicosis	MESH:D006111
9653867	65	81	Eating disorders	MESH:D001068
9653867	583	599	eating disorders	MESH:D001068
9653867	637	651	thyrotoxicosis	MESH:D006111
17608141	39	79	nigrostriatal dopaminergic neurotoxicity	MESH:D020258
17608141	209	237	dopaminergic terminal damage	MESH:D001925
17608141	395	431	nigrostriatal dopamine neurotoxicity	MESH:D020258
17608141	535	547	hyperthermia	MESH:D005334
17608141	1469	1505	nigrostriatal dopamine neurotoxicity	MESH:D020258
2559236	75	86	nephropathy	OMIM:161900
2559236	166	184	Munich-Wistar rats	MESH:D011906
2559236	202	222	adriamycin nephrosis	MESH:D009401
2559236	325	336	albuminuria	MESH:D000419
2559236	768	779	albuminuria	MESH:D000419
2559236	970	982	renal injury	MESH:D058186
2559236	986	1006	adriamycin nephrosis	MESH:D009401
2559236	1076	1087	albuminuria	MESH:D000419
2559236	1471	1491	glomerular sclerosis	MESH:D007673
10901305	569	586	isolated fracture	MESH:D014082
10901305	1254	1260	CHEOPS
10901305	1203	1252	Children's Hospital of Eastern Ontario Pain Scale	MESH:D010146
10901305	2347	2365	dysphoric reaction	MESH:D012183
19037603	74	97	rheumatologic disorders	MESH:D009358
19037603	237	246	hepatitis	MESH:D006505
19037603	303	324	rheumatologic disease	MESH:D004194
19037603	391	413	rheumatologic diseases	MESH:D004194
19037603	542	559	hepatitis B virus	MESH:D006509
19037603	561	564	HBV	MESH:D006509
20084309	114	140	semi-invasive tool broadly	MESH:D009361
20084309	595	597	MZ
20084309	734	748	myocardiopathy	MESH:D009202
20084309	750	752	MP	MESH:C535959
20084309	1091	1103	Mild hypoxia	MESH:D000860
20084309	1105	1108	SO2
20084309	1191	1198	hypoxia	MESH:D000860
20084309	1273	1280	hypoxia	MESH:D000860
20084309	1322	1325	SAP	OMIM:611721
20084309	1526	1528	MP	MESH:C535959
10091617	43	62	Parkinson's disease	MESH:D010300
10091617	247	266	Parkinson's disease	MESH:D010300
10091617	268	270	PD	OMIM:168600
10091617	623	640	autonomic failure	MESH:D012791
10091617	1035	1037	PD	OMIM:168600
10091617	1191	1193	PD	OMIM:168600
10091617	1303	1326	orthostatic hypotension	MESH:D007024
10091617	1351	1374	Orthostatic hypotension	MESH:D007024
3070035	35	54	renal insufficiency	MESH:D051437
3070035	97	122	renovascular hypertension	MESH:D006978
3070035	181	193	renal artery	MESH:D012078
3070035	199	214	solitary kidney	MESH:D001845
3070035	230	250	sudden deterioration	MESH:D003639
3070035	309	323	renal function	OMIM:608852
3070035	515	528	renal failure	MESH:D051437
3070035	604	625	glomerular arterioles	MESH:D007673
1147734	0	13	Liver disease	MESH:D008107
1147734	163	192	active (aggressive) hepatitis	MESH:D006521
1147734	329	350	chronic liver disease	MESH:D008107
12202650	110	145	painful temporomandibular disorders	MESH:D013001
18951540	66	77	dyskinesias	MESH:D020820
18951540	282	298	dose dyskinesias	MESH:D020820
18951540	316	335	Parkinson's disease	MESH:D010300
18951540	337	339	PD	OMIM:168600
18951540	360	388	PD and prominent dyskinesias	OMIM:168600
18951540	845	864	dyskinesia severity	MESH:D020820
18951540	926	934	dystonia	MESH:D004421
18951540	1405	1416	dyskinesias	MESH:D020820
18951540	1420	1422	PD	OMIM:168600
19657887	0	24	Disulfiram-like syndrome	MESH:C536855
19657887	338	359	acetaldehyde syndrome	MESH:D013577
19657887	441	465	disulfiram-like syndrome	MESH:C536855
19657887	791	802	tachycardia	MESH:D013610
19657887	808	815	dyspnea	MESH:D004417
19657887	1022	1046	disulfiram-like syndrome	MESH:C536855
19657887	1062	1073	tachycardia	MESH:D013610
19657887	1079	1099	arterial hypotension	MESH:D007022
9660111	619	630	Wistar rats	MESH:D011906
9660111	758	779	reserpine hypothermia	MESH:D007035
11431197	19	47	acute interstitial nephritis	MESH:D009395
11431197	220	266	acute interstitial nephritis in native kidneys	MESH:D009395
11431197	364	392	acute interstitial nephritis	MESH:D009395
11431197	455	482	acute allograft dysfunction	MESH:D000208
7449470	39	55	Cardiac toxicity	MESH:D056486
7449470	144	158	Cardiomyopathy	MESH:D009202
7449470	321	335	cardiomyopathy	MESH:D009202
8170551	22	37	nephrolithiasis	MESH:D053040
8170551	69	92	neuromuscular disorders	MESH:D009468
8170551	94	123	Carbonic anhydrase inhibitors	MESH:C536058
8170551	134	149	nephrolithiasis	MESH:D053040
8170551	260	268	myotonia	MESH:D009222
8170551	318	331	renal calculi	MESH:D007669
8170551	545	560	Nephrolithiasis	MESH:D053040
2476560	439	455	aplastic anaemia	MESH:D000741
19803309	83	101	myotonia congenita	MESH:D009224
19803309	136	154	myotonia congenita	MESH:D009224
18821488	329	341	CN poisoning	MESH:D011041
18821488	976	993	methemoglobinemia	MESH:D008708
18821488	1133	1147	hemoglobinuria	MESH:D006456
18821488	1306	1319	Myoglobinuria	MESH:D009212
18821488	1428	1453	liver and kidney toxicity	MESH:D056486
18821488	1663	1665	CN
15338796	523	547	obstructive lung disease	MESH:D008173
12627929	23	45	venous thromboembolism	MESH:D054556
12627929	145	160	prostate cancer	MESH:D011471
12627929	215	230	thromboembolism	MESH:D013923
12627929	284	299	prostate cancer	MESH:D011471
12627929	578	593	prostate cancer	MESH:D011471
12627929	886	904	excessive toxicity	MESH:D056486
12627929	1193	1208	prostate cancer	MESH:D011471
6634932	207	231	ventricular tachycardias	MESH:D017180
6634932	339	362	ventricular tachycardia	MESH:D017180
18791946	7	23	thrombocytopenia	MESH:D013921
18791946	28	46	haemolytic anaemia	MESH:C536356
18791946	357	380	urinary tract infection	MESH:D014552
18791946	444	460	thrombocytopenia	MESH:D013921
18791946	465	475	haemolysis
18791946	842	859	microangiopathies	MESH:D059345
18791946	1030	1046	thrombocytopenia	MESH:D013921
18791946	1051	1069	haemolytic anaemia	MESH:C536356
17344566	20	54	bilateral leg compartment syndrome	MESH:D003161
17344566	59	70	myonecrosis
17344566	87	101	hypothyroidism	MESH:D007037
17344566	129	150	male taking thyroxine	OMIM:601696
17344566	182	216	bilateral leg compartment syndrome	MESH:D003161
17344566	221	232	myonecrosis
17344566	480	493	arteriopathic
9293063	104	123	bile duct hamartoma	MESH:D001649
1728522	0	23	Granulomatous hepatitis	MESH:D006505
1728522	152	161	hepatitis	MESH:D006505
1728522	167	197	histologic multiple granulomas	MESH:D009370
1728522	311	338	benign cholestatic syndrome	MESH:D041781
1728522	359	369	granulomas	MESH:D006099
1728522	374	392	eosinophilia favor	MESH:D004802
10807237	54	75	prognostic indicators
10807237	103	126	subarachnoid hemorrhage	MESH:D013345
10807237	610	633	subarachnoid hemorrhage	MESH:D013345
10807237	977	986	aneurysms	MESH:D000783
10807237	1344	1362	aneurysmal rupture	MESH:D017542
12536034	1002	1018	absence epilepsy	MESH:D004832
7234705	21	57	polymorphous ventricular tachycardia	MESH:C536334
7234705	95	131	polymorphous ventricular tachycardia	MESH:C536334
7234705	165	201	polymorphous ventricular tachycardia	MESH:C536334
7234705	298	331	sustained ventricular tachycardia	MESH:D017180
7234705	466	480	atrial flutter	MESH:D001282
7234705	501	504	Q-T	MESH:D011778
7234705	547	583	polymorphous ventricular tachycardia	MESH:C536334
7234705	607	617	arrhythmia	MESH:D001145
7234705	698	708	arrhythmia	MESH:D001145
7234705	731	741	arrhythmia	MESH:D001145
7234705	759	796	irreversible ventricular fibrillation	MESH:D014693
7234705	857	878	ventricular pacemaker	MESH:D018754
7234705	956	979	ventricular tachycardia	MESH:D017180
7234705	1079	1091	Q-T syndrome	MESH:D011778
7234705	1097	1133	polymorphous ventricular tachycardia	MESH:C536334
11532387	0	35	Withdrawal-emergent rabbit syndrome	MESH:D004630
11532387	74	89	Rabbit syndrome	MESH:D013577
11532387	91	93	RS	MESH:D041441
11532387	295	297	RS	MESH:D041441
11532387	680	682	RS	MESH:D041441
3173179	44	65	myocardial infarction	MESH:D009203
3173179	280	301	cardiac contractility	MESH:D006331
3173179	408	429	myocardial infarction	MESH:D009203
3856631	23	41	meningeal leukemia	MESH:D008581
3856631	110	132	lymphoblastic leukemia	MESH:D054198
3856631	147	164	meningeal disease	MESH:D008581
3856631	1136	1147	neutropenia	MESH:D009503
3856631	1153	1162	mucositis	MESH:D052016
3856631	1366	1394	acute lymphoblastic leukemia	MESH:D054198
2522601	52	70	leukemoid reaction	MESH:D007955
2522601	72	84	eosinophilia	MESH:D004802
2522601	86	98	erythroderma	MESH:D003873
2522601	104	117	renal failure	MESH:D051437
2522601	196	220	generalized erythroderma	MESH:D003873
2522601	231	240	leukemoid	MESH:D007955
2522601	251	263	eosinophilia	MESH:D004802
2522601	265	277	hyponatremia	MESH:D007010
2522601	283	296	renal failure	MESH:D051437
8741744	81	96	Partial lesions	MESH:D004828
8741744	415	428	hyperactivity	MESH:D006948
17491223	98	117	myocardial ischemia	MESH:D017202
17491223	210	229	myocardial ischemia	MESH:D017202
17491223	348	363	brachial artery	MESH:D020968
17491223	448	467	myocardial ischemia	MESH:D017202
17491223	606	614	ischemia	MESH:D007511
17491223	751	766	brachial artery	MESH:D020968
17491223	876	884	ischemia	MESH:D007511
17491223	1515	1530	cardiac imaging	OMIM:300290
17491223	1562	1581	myocardial ischemia	MESH:D017202
18004067	371	384	liver failure	MESH:D017093
18004067	635	649	hepatotoxicity
17615423	7	21	rhabdomyolysis	MESH:D012206
17615423	26	45	acute renal failure	MESH:D058186
17615423	232	246	rhabdomyolysis	MESH:D012206
17615423	251	270	acute renal failure	MESH:D058186
17615423	324	352	human immunodeficiency virus	MESH:D015658
17615423	354	373	atrial fibrillation	MESH:D001281
17615423	375	398	coronary artery disease	MESH:D003324
17615423	404	418	hyperlipidemia	MESH:D006949
17615423	976	992	immunodeficiency	MESH:C538675
17615423	1078	1095	alkaline diuresis
17615423	1354	1368	rhabdomyolysis	MESH:D012206
8558192	58	78	esophageal carcinoma	MESH:D004941
8558192	132	168	Cancer Gastrointestinal Treat Cancer	MESH:D009369
8558192	325	345	esophageal carcinoma	MESH:D004941
8558192	1189	1192	VNB
8558192	1246	1269	nonhematologic toxicity	MESH:D056486
8558192	1424	1436	toxic deaths	MESH:D056486
8558192	1599	1644	metastatic esophageal squamous cell carcinoma	MESH:D002294
8558192	1724	1727	VNB
11135224	115	154	metastatic nonsmall cell lung carcinoma	MESH:C538445
11135224	250	287	advanced nonsmall cell lung carcinoma	MESH:D055752
11135224	650	664	Stage IV NSCLC	MESH:D007676
11135224	1800	1816	thrombocytopenia	MESH:D013921
11135224	1911	1936	Nonhematologic toxicities	MESH:D056486
8590259	415	438	upper and lower eyelids	MESH:D005141
8590259	973	982	mydriasis	MESH:D015878
2096243	17	41	organic mental disorders	MESH:D019965
2096243	43	66	Organic mental disorder	MESH:D019965
2096243	165	184	leukoencephalopathy	MESH:D056784
2096243	203	211	euphoria
2096243	292	320	organic personality syndrome	MESH:D010554
2096243	396	417	frontal lobe syndrome	MESH:D017034
2096243	625	644	leukoencephalopathy	MESH:D056784
2096243	670	698	organic personality syndrome	MESH:D010554
6209318	81	91	arrhythmia	MESH:D001145
6209318	302	334	documented myocardial infarction	MESH:D009203
3615541	63	76	hyperactivity	MESH:D006948
3615541	768	780	hypothalamus	MESH:D007029
3615541	785	802	nucleus accumbens	MESH:D002527
8953972	202	217	pulmonary edema	MESH:D011654
8953972	253	273	respiratory distress	MESH:D012127
8953972	434	457	subarachnoid hemorrhage	MESH:D013345
3782049	10	32	massive rhabdomyolysis	MESH:D012206
3782049	89	116	potentially lethal syndrome	MESH:C537245
3782049	122	133	psychiatric	MESH:D005329
3782049	255	269	rhabdomyolysis	MESH:D012206
3782049	355	369	rhabdomyolysis	MESH:D012206
3782049	385	404	acute renal failure	MESH:D058186
9100294	794	822	cardiovascular malformations	MESH:D002318
19889778	106	115	hepatitis	MESH:D006505
19889778	196	213	hepatitis B virus	MESH:D006509
19889778	215	218	HBV	MESH:D006509
19889778	1216	1218	PC	MESH:D015324
19889778	1222	1225	BCP
17042910	151	219	endothelial dysfunction associated with nitric oxide (NO) deficiency	MESH:D028361
17042910	557	580	endothelial NO synthase	MESH:D002311
17042910	646	648	SD	MESH:D029461
17042910	630	644	Sprague-Dawley
17042910	582	586	eNOS
17042910	1988	1991	SBP
11897407	55	76	myocardial infarction	MESH:D009203
11897407	168	195	acute myocardial infarction	MESH:D009203
11897407	582	609	acute myocardial infarction	MESH:D009203
11897407	1196	1214	cardiac infarction	MESH:D007238
9812111	1949	1958	psychosis	MESH:D011618
15572383	26	35	renal ACE	MESH:D007680
15572383	87	118	adriamycin-induced renal damage	MESH:D001925
15572383	250	265	renal prognosis	MESH:D007680
15572383	325	334	renal ACE	MESH:D007680
15572383	449	458	renal ACE	MESH:D007680
15572383	563	581	Renal ACE activity	OMIM:612348
15572383	677	688	Wistar rats	MESH:D011906
15572383	824	835	Proteinuria	MESH:D011507
15572383	975	1002	nephrotic range proteinuria	MESH:D011507
15572383	1004	1029	renal interstitial damage	MESH:D001925
15572383	1039	1063	focal glomerulosclerosis	MESH:D005923
15572383	1489	1507	glomerulosclerosis	MESH:D003928
15572383	1632	1650	renal ACE activity	OMIM:612348
15572383	1694	1706	renal damage	MESH:D001925
15572383	1845	1857	renal damage	MESH:D001925
7420681	9	37	nephrotoxicity of tobramycin
7420681	244	258	nephrotoxicity
7420681	528	564	aminoglycoside-related renal failure	OMIM:580000
7420681	669	682	renal failure	MESH:D051437
7420681	816	829	renal failure	MESH:D051437
7420681	868	881	renal failure	MESH:D051437
12907309	185	197	hyperthermia	MESH:D005334
12907309	1084	1096	hyperthermia	MESH:D005334
12907309	1101	1131	reduced basal body temperature	MESH:D001832
12907309	1663	1675	hyperthermia	MESH:D005334
17532790	75	85	dyskinesia	MESH:D020820
17532790	102	112	dyskinesia	MESH:D020820
17532790	114	117	LID
17532790	166	185	Parkinson's disease	MESH:D010300
17532790	187	189	PD	OMIM:168600
17532790	703	705	MS	MESH:D009103
17532790	684	701	mass spectrometry	MESH:C536030
17532790	1090	1092	MS	MESH:D009103
17532790	1093	1095	MS	MESH:D009103
17532790	1562	1565	LID
7582165	244	253	urticaria	MESH:D014581
16787750	22	36	encephalopathy	MESH:D001925
16787750	304	329	haemorrhagic pancreatitis	MESH:D010195
16787750	356	382	VPA-induced hepatotoxicity	MESH:D020751
16787750	399	413	encephalopathy	MESH:D001925
16787750	448	462	encephalopathy	MESH:D001925
16787750	577	591	hyperammonemia	MESH:D022124
16787750	661	675	encephalopathy	MESH:D001925
16787750	764	793	VPA-associated encephalopathy	MESH:D001925
3173180	0	27	Haemolytic-uraemic syndrome	MESH:C536356
3173180	141	168	haemolytic-uraemic syndrome	MESH:C536356
3173180	399	426	haemolytic-uraemic syndrome	MESH:C536356
3173180	575	602	haemolytic-uraemic syndrome	MESH:C536356
3173180	681	708	haemolytic-uraemic syndrome	MESH:C536356
8996652	16	42	sensorineural hearing loss	MESH:D006319
8996652	182	234	progressive and bilateral sensorineural hearing loss	MESH:D006319
8996652	275	287	hearing loss	MESH:D034381
8996652	455	467	hearing loss	MESH:D034381
84204	54	92	cimetidine-associated mental confusion	MESH:D003221
84204	106	144	cimetidine-associated mental confusion	MESH:D003221
84204	226	239	mental status	MESH:D013226
84204	241	245	M.S.	MESH:C535314
84204	445	472	renal and liver dysfunction	MESH:D008107
84204	1054	1090	severe renal and hepatic dysfunction	MESH:D006505
15515654	167	179	hearing loss	MESH:D034381
15515654	496	499	DFO
15515654	479	494	desferrioxamine
15515654	804	830	sensorineural hearing loss	MESH:D006319
15515654	832	836	SNHL
15515654	1392	1410	hearing impairment	MESH:D034381
15515654	1463	1474	thalassemic
2024540	122	146	congestive heart failure	MESH:D006333
2024540	268	292	congestive heart failure	MESH:D006333
12090760	88	94	anemia	MESH:D000740
12090760	162	168	anemia	MESH:D000740
7516729	318	320	BF
7516729	301	316	Basal frequency	MESH:D006316
7516729	920	931	bradycardia	MESH:D001919
7516729	1262	1276	atrial beating	MESH:D018880
7516729	1389	1415	atrial spontaneous beating	MESH:D018880
7516729	1555	1569	atrial beating	MESH:D018880
2802551	664	699	cytoplasmic degeneration in tubules	MESH:D007673
2802551	1070	1076	plasma	MESH:D054219
19346865	0	37	Reversible inferior colliculus lesion	MESH:D056989
19346865	63	77	encephalopathy	MESH:D001925
19346865	208	246	reversible inferior colliculus lesions	MESH:D056989
19346865	272	286	encephalopathy	MESH:D001925
19346865	533	547	encephalopathy	MESH:D001925
19346865	1684	1687	DWI
19346865	1869	1884	callosal lesion	MESH:D002145
19346865	1909	1947	Reversible inferior colliculus lesions	MESH:D056989
19346865	2016	2030	encephalopathy	MESH:D001925
2334618	789	805	tachyarrhythmias	MESH:D013610
8864707	186	204	cerebellar atrophy	MESH:D002526
8864707	637	652	volumetric data
8864707	883	909	compare cerebellar volumes	MESH:D002526
8864707	1274	1292	cerebellar atrophy	MESH:D002526
8864707	1360	1378	cerebellar atrophy	MESH:D002526
8864707	1509	1529	cerebellar disorders	MESH:D002526
12589964	60	77	myocardial damage	MESH:D001925
12589964	101	115	cardiomyopathy	MESH:D009202
12589964	310	332	myocardial cell injury	MESH:D009202
12589964	409	426	myocardial damage	MESH:D001925
12589964	471	485	cardiomyopathy	MESH:D009202
12589964	573	590	cardiac disorders	MESH:D006331
12589964	687	698	Wistar rats	MESH:D011906
12589964	1006	1043	anterior and posterior wall thickness	MESH:D056988
12589964	1088	1090	FS
12589964	1065	1086	fractional shortening	MESH:C535850
12589964	1410	1412	ED	MESH:C536181
12589964	1488	1490	FS
12589964	1395	1408	End-diastolic	MESH:D006337
12589964	2440	2442	ED	MESH:C536181
12589964	2447	2465	ES LV diameters/BW	MESH:D012512
12589964	2633	2635	BW
12589964	2693	2701	ischemic	MESH:D002545
11263551	30	43	pain syndrome	MESH:C538101
11263551	45	49	CIPS
11263551	491	509	bone marrow oedema	MESH:D001855
11263551	616	625	dystrophy	MESH:D009136
11263551	627	641	polyneuropathy	MESH:D011115
11263551	652	661	neuralgia	MESH:D009437
11263551	669	681	osteoporosis	MESH:D010024
11263551	683	701	avascular necrosis	MESH:D010020
11263551	742	758	foot deformities	MESH:D005530
11263551	760	776	stress fractures	MESH:D015775
11263551	782	801	hyperparathyroidism	MESH:D006961
11263551	970	983	Pain Syndrome	MESH:C538101
11263551	985	989	CIPS
10520387	933	952	myocardial ischemia	MESH:D017202
230316	520	544	neurological disturbance	MESH:D014832
230316	578	592	encephalopathy	MESH:D001925
230316	863	877	acrodermatitis	MESH:D000169
230316	934	944	myelopathy	MESH:D013118
230316	946	964	visual disturbance	MESH:D012640
230316	981	991	neuropathy	MESH:D003929
230316	1027	1046	Isolated myelopathy	MESH:D013118
230316	1061	1071	neuropathy	MESH:D003929
230316	1174	1194	toxic encephalopathy	MESH:D020258
230316	1325	1356	subacute myelo-optic neuropathy	MESH:D009901
11807648	134	136	FS
11807648	117	132	Fibrin sealants
11807648	576	578	FS
11807648	892	900	FINDINGS	MESH:D009461
14596845	227	240	neurochemical
6666578	24	34	angiopathy	MESH:D003925
11279304	44	80	anthracycline-induced cardiotoxicity	MESH:D020751
11279304	159	186	dose-related cardiotoxicity	MESH:D019973
11279304	337	356	cardiac dysfunction	MESH:D006331
11279304	443	446	BNP
11279304	495	531	anthracycline-induced cardiotoxicity	MESH:D020751
11279304	549	563	acute leukemia	MESH:D054198
11279304	390	415	brain natriuretic peptide	MESH:C536656
11279304	641	655	acute leukemia	MESH:D054198
11279304	835	838	ANP
11279304	807	833	atrial natriuretic peptide	MESH:C536656
11279304	928	952	congestive heart failure	MESH:D006333
11279304	1042	1055	heart failure	MESH:D006333
11279304	1169	1182	heart failure	MESH:D006333
11279304	1275	1288	heart failure	MESH:D006333
11279304	1382	1395	heart failure	MESH:D006333
11279304	1536	1549	heart failure	MESH:D006333
11279304	1624	1683	sensitive indicator of anthracycline-induced cardiotoxicity	MESH:D007333
19884587	960	971	anencephaly	MESH:D000757
19884587	1038	1069	hypoplastic left heart syndrome	MESH:D018636
19884587	1155	1170	choanal atresia	MESH:D002754
19884587	1172	1175	AOR
19884587	1202	1228	transverse limb deficiency	MESH:C537446
19884587	1263	1283	diaphragmatic hernia	MESH:D006548
19884587	1351	1363	anophthalmia	MESH:D000853
19884587	1367	1381	microphthalmos	MESH:D008850
19884587	1413	1444	hypoplastic left heart syndrome	MESH:D018636
19884587	1446	1449	AOR
19884587	1475	1496	atrial septal defects	MESH:D006344
19884587	1531	1540	cleft lip	MESH:D002971
19884587	1546	1558	cleft palate	MESH:D002972
3970039	13	22	neoplasms	MESH:D009369
3970039	40	60	rheumatoid arthritis	MESH:D001172
3970039	203	223	rheumatoid arthritis	MESH:D001172
3970039	447	456	synovitis	MESH:D013585
3970039	886	915	acute nonlymphocytic leukemia	MESH:D015470
3970039	1071	1095	carcinoma of the bladder	MESH:D001745
3970039	1156	1176	rheumatoid arthritis	MESH:D001172
3970039	1264	1271	cancers	MESH:D009369
3970039	1343	1363	rheumatoid arthritis	MESH:D001172
3970039	1523	1543	rheumatoid arthritis	MESH:D001172
3970039	1588	1607	progressive disease	MESH:D018450
424937	71	84	liver disease	MESH:D008107
424937	96	106	methyldopa
424937	348	367	tender hepatomegaly	MESH:D006529
424937	401	439	malaise, anorexia, nausea and vomiting	MESH:D020250
424937	643	657	hepatic injury	MESH:D006505
424937	710	739	focal hepatocellular necrosis	MESH:D006528
424937	751	767	hepatic necrosis	MESH:D009336
424937	809	824	acute hepatitis	MESH:D017114
424937	828	852	chronic active hepatitis	MESH:D006521
424937	1025	1040	hepatic failure	MESH:D017093
424937	1238	1247	hepatitis	MESH:D006505
424937	1342	1351	hepatitis	MESH:D006505
424937	1426	1436	methyldopa
424937	1441	1460	hepatic dysfunction	MESH:D006505
424937	1495	1504	hepatitis	MESH:D006505
8643971	83	95	neck cancers	MESH:D006258
8643971	156	180	head and neck carcinomas	MESH:D006258
8643971	442	453	neck cancer	MESH:D006258
8643971	582	596	ovarian cancer	MESH:D010051
8643971	859	873	neck carcinoma	MESH:D006258
8643971	973	986	Primary tumor	MESH:D001932
8643971	1212	1228	stage IV disease	MESH:D007676
8643971	2233	2245	paresthesias	MESH:D010292
8643971	2251	2262	arthralgias	MESH:D018771
8643971	2263	2271	myalgias	MESH:D011000
8643971	2332	2339	myalgia	MESH:D011000
8643971	2516	2527	neck cancer	MESH:D006258
2224762	242	259	refractory tumors	MESH:D000753
2224762	367	399	renal and/or hepatic dysfunction	MESH:D006505
2224762	724	740	thrombocytopenia	MESH:D013921
2224762	742	748	anemia	MESH:D000740
2224762	750	756	nausea	MESH:D009325
2224762	763	771	alopecia	MESH:D000505
2224762	773	782	phlebitis	MESH:D010689
2224762	788	797	mucositis	MESH:D052016
2224762	842	861	hepatic dysfunction	MESH:D006505
2224762	1207	1282	Adriamycinol, doxorubicin, adriamycinone, and tetrahydropyranyladriamycinol
2224762	1531	1545	leiomyosarcoma	MESH:D007890
2224762	1551	1571	basal cell carcinoma	MESH:D002280
12483326	93	106	glioblastomas	MESH:D005909
12483326	120	132	Glioblastoma	MESH:D005909
12483326	148	153	tumor	MESH:D009369
12483326	393	405	glioblastoma	MESH:D005909
12483326	853	866	glioblastomas	MESH:D005909
12483326	1271	1279	glaucoma	MESH:D005901
12483326	1329	1373	papilledema and exudative retinal detachment	MESH:D012163
12483326	1429	1450	chorioretinal atrophy	MESH:D002825
12483326	1456	1469	optic atrophy	MESH:D009896
12483326	1501	1509	left eye	MESH:D005128
1664218	64	90	non-small cell lung cancer	MESH:D002289
1664218	256	266	antitumour
1664218	346	372	non-small cell lung cancer	MESH:D002289
1664218	374	379	NSCLC
1664218	605	608	WHO
1664218	663	681	squamous carcinoma	MESH:D002294
1664218	688	702	adenocarcinoma	MESH:D000230
1664218	729	756	bronchio-alveolar carcinoma	MESH:D002282
1664218	765	802	large cell undifferentiated carcinoma	MESH:D002277
1664218	1077	1100	squamous cell carcinoma	MESH:D002294
1664218	1181	1187	tumour	MESH:D015275
18809400	95	105	neuropathy	MESH:D003929
18809400	199	212	neurotoxicity	MESH:D020258
18809400	444	454	neuropathy	MESH:D003929
18809400	528	548	dorsal root ganglion	MESH:D011843
18809400	550	553	DRG
18809400	1146	1159	neurotoxicity	MESH:D020258
18809400	1440	1453	neurotoxicity	MESH:D020258
17020434	32	64	non-valvular atrial fibrillation	MESH:D001281
17020434	66	85	Atrial fibrillation	MESH:D001281
17020434	975	994	atrial fibrillation	MESH:D001281
17020434	1096	1115	atrial fibrillation	MESH:D001281
3865016	34	48	antineoplastic
3865016	140	168	acute T-lymphocytic leukemia	MESH:D054218
3865016	351	376	terms of mental confusion	MESH:D003221
3865016	393	411	hyperbilirubinemia	MESH:D006932
3865016	458	480	antineoplastic effects	MESH:D007088
3629586	85	113	cephalosporin hematotoxicity
3629586	167	191	hematologic disturbances	MESH:D006402
3629586	338	354	blood dyscrasias	MESH:D010265
3629586	516	522	anemia	MESH:D000740
3629586	524	535	neutropenia	MESH:D009503
3629586	541	557	thrombocytopenia	MESH:D013921
3629586	607	613	anemia	MESH:D000740
3629586	773	783	cytopenias
3629586	1036	1075	cephalosporin, the hematologic syndrome	MESH:D006402
3629586	1689	1705	blood dyscrasias	MESH:D010265
150790	23	42	behavioral disorder	MESH:D001523
150790	119	131	hyperkinesis	MESH:D006948
10579464	945	954	catalepsy	MESH:D002375
3496378	51	66	acute hepatitis	MESH:D017114
3496378	131	140	hepatitis	MESH:D006505
3496378	282	299	hypereosinophilia	MESH:C538564
3496378	602	611	hepatitis	MESH:D006505
3496378	704	719	acute hepatitis	MESH:D017114
3076126	131	145	hypolipidaemic
3076126	1315	1323	Myopathy	MESH:D009135
3076126	1355	1368	myoglobinuria	MESH:D009212
3076126	1400	1413	renal failure	MESH:D051437
3076126	1778	1799	hypercholesterolaemia
2894766	0	41	Sulfasalazine-induced lupus erythematosus	MESH:D008180
2894766	43	54	Pneumonitis	MESH:D011014
2894766	248	274	chronic ulcerative colitis	MESH:D003093
2894766	518	527	serositis	MESH:D012700
2894766	656	682	inflammatory bowel disease	MESH:D015212
2894766	715	751	sulfasalazine-induced lupus syndrome	MESH:C536397
1549199	685	711	gastrointestinal disorders	MESH:D005767
1549199	713	736	orthostatic hypotension	MESH:D007024
1549199	755	764	psychosis	MESH:D011618
1549199	788	799	parasomnias	MESH:D020447
1549199	878	903	Nonpharmacologic concerns
1549199	917	936	Parkinson's disease	MESH:D010300
88336	58	74	cerebral hypoxia	MESH:D002534
88336	1058	1068	alpha coma	MESH:D003128
88336	1209	1219	hypoxaemia
18544179	1743	1754	bradycardia	MESH:D001919
18186898	0	22	Renal Fanconi syndrome	MESH:D005198
18186898	27	35	myopathy	MESH:D009135
18186898	92	101	cytopathy	MESH:D007625
18186898	444	460	Wilson's disease	MESH:D006527
18186898	565	574	hepatitis	MESH:D006505
18186898	654	676	renal Fanconi syndrome	MESH:D005198
18186898	689	707	metabolic acidosis	MESH:D000138
18186898	709	725	hypophosphatemia	MESH:D017674
18186898	727	737	glycosuria	MESH:D006029
18186898	743	756	aminoaciduria	MESH:D000608
18186898	934	949	muscle weakness	MESH:D018908
18186898	986	1002	Fanconi syndrome	MESH:D005198
18186898	1015	1023	myopathy	MESH:D009135
18186898	1061	1084	mitochondrial disorders	MESH:D028361
18186898	1149	1168	tubular dysfunction	MESH:D005198
18186898	1173	1181	myopathy	MESH:D009135
16867021	195	208	schizophrenia	MESH:D012559
16867021	734	743	catalepsy	MESH:D002375
16867021	1174	1187	hyperactivity	MESH:D006948
16867021	1472	1475	THP
16867021	1616	1625	catalepsy	MESH:D002375
16867021	1656	1669	hyperactivity	MESH:D006948
16867021	1737	1740	THP
16867021	1915	1928	schizophrenia	MESH:D012559
14976857	10	45	platypnea-orthodeoxia-like syndrome	MESH:C536855
14976857	224	237	rare syndrome	MESH:D035583
14976857	245	266	platypnea-orthodeoxia
14976857	352	359	hypoxia	MESH:D000860
14976857	364	372	cyanosis	MESH:D003490
14976857	559	584	biventricular dysfunction	MESH:D018754
11745184	60	87	metastatic breast carcinoma	MESH:D058922
11745184	243	270	metastatic breast carcinoma	MESH:D058922
11745184	519	533	nephrotoxicity
11745184	607	623	breast carcinoma	MESH:D058922
11745184	1018	1032	nephrotoxicity
11745184	1051	1061	neuropathy	MESH:D003929
11745184	1193	1220	metastatic breast carcinoma	MESH:D058922
11745184	1291	1309	metastatic disease	MESH:C538219
11745184	1940	1959	Neurologic toxicity	MESH:D056486
11745184	2216	2221	tumor	MESH:D009369
3985451	285	303	iliopsoas hematoma	MESH:D016659
3985451	516	526	neuropathy	MESH:D003929
3985451	606	634	motor and sensory impairment	MESH:D015417
3750012	0	17	Myasthenia gravis	MESH:D009157
3750012	70	90	rheumatoid arthritis	MESH:D001172
3750012	163	180	myasthenia gravis	MESH:D009157
3750012	229	249	rheumatoid arthritis	MESH:D001172
3750012	354	372	autoimmune process	MESH:D010335
1130930	82	104	acute tubular necrosis	MESH:D007683
1130930	149	162	renal failure	MESH:D051437
1130930	352	366	nephrotoxicity
1130930	474	493	renal insufficiency	MESH:D051437
19356307	20	52	essential oil attenuate dementia	MESH:D003704
19356307	470	473	OFH
15957009	120	137	memory deficiency	MESH:D008569
15957009	1124	1139	memory deficits	MESH:D008569
15957009	1348	1375	serotonergic memory deficit	MESH:D008569
15899738	0	24	Lone atrial fibrillation	MESH:D001281
15899738	79	98	Atrial fibrillation	MESH:D001281
15899738	136	149	heart disease	MESH:D006331
15899738	179	189	arrhythmia	MESH:D001145
15899738	272	289	Thyroid disorders	MESH:D013966
15899738	326	352	acute alcohol intoxication	MESH:D000435
15899738	467	486	atrial fibrillation	MESH:D001281
15899738	1522	1532	arrhythmia	MESH:D001145
15863244	0	36	Comparison of developmental toxicity	MESH:D056486
15863244	104	106	WI
15863244	757	760	DFU
15863244	939	942	VSD	MESH:D004310
15863244	957	959	MD	MESH:C535955
15863244	948	955	midline	MESH:C538667
15863244	1129	1160	intrauterine growth retardation	MESH:D005317
15863244	1549	1552	VSD	MESH:D004310
15863244	1557	1559	MD	MESH:C535955
15863244	1899	1937	ventricular septal and midline defects	MESH:D006345
12921865	194	215	psychiatric disorders	MESH:D005329
12921865	1391	1411	cumulative lethality	MESH:D012090
12584269	305	324	nephrotoxic effects	MESH:D007088
12584269	405	408	SRL
12584269	480	498	nephrotoxic effect	MESH:D007088
12584269	1294	1310	striped fibrosis	MESH:D005355
12584269	1351	1369	basophilic tubules	MESH:D000237
12584269	1989	1997	fibrosis	MESH:D005355
12584269	2180	2188	fibrosis	MESH:D005355
10406016	166	174	ischemic	MESH:D002545
10406016	593	601	hematoma	MESH:D006406
10406016	847	863	larger hematomas	MESH:D006406
10406016	925	933	hematoma	MESH:D006406
10406016	1129	1141	matter edema	MESH:D004487
10406016	1155	1168	neuronal loss	MESH:D016388
10406016	1201	1209	hematoma	MESH:D006406
3403780	0	27	Paracetamol-associated coma	MESH:D003128
3403780	29	47	metabolic acidosis	MESH:D000138
3403780	49	74	renal and hepatic failure	MESH:D017093
3403780	86	104	metabolic acidosis	MESH:D000138
3403780	106	125	acute renal failure	MESH:D058186
3403780	130	145	hepatic failure	MESH:D017093
3101906	270	281	five deaths	MESH:D003643
3101906	377	389	three deaths	MESH:D003643
3101906	1166	1178	eosinophilia	MESH:D004802
3101906	1190	1199	Hepatitis	MESH:D006505
3101906	1358	1370	three deaths	MESH:D003643
3101906	1497	1506	hepatitis	MESH:D006505
3101906	1581	1590	hepatitis	MESH:D006505
9088814	71	84	haemodilution
9088814	190	203	haemodilution
9088814	525	538	haemodilution
9088814	885	911	arterial ketone body ratio	MESH:D002539
9088814	913	917	AKBR
20880751	17	28	dyskinesias	MESH:D020820
20880751	46	65	Parkinson's disease	MESH:D010300
20880751	285	296	dyskinesias	MESH:D020820
20880751	436	464	levodopa-induced dyskinesias	MESH:D004409
20880751	721	741	dyskinetic movements	MESH:D002547
20880751	1057	1068	dyskinesias	MESH:D020820
20080419	487	490	SRS	MESH:D056730
20080419	477	485	seizures	MESH:D012640
20080419	1403	1416	neuronal loss	MESH:D016388
19445921	71	92	myocardial infarction	MESH:D009203
19445921	223	244	myocardial infarction	MESH:D009203
19445921	951	971	ventricular pressure	MESH:D003668
19445921	1311	1330	cardiac dysfunction	MESH:D006331
19445921	1335	1352	myocardial injury	MESH:D009202
19445921	1474	1491	myocardial damage	MESH:D001925
19445921	1703	1724	myocardial infarction	MESH:D009203
18439803	477	479	ED	MESH:C536181
17919553	0	15	Acute hepatitis	MESH:D017114
17919553	1130	1139	hepatitis	MESH:D006505
17919553	1449	1468	hepatic dysfunction	MESH:D006505
17919553	1588	1603	acute hepatitis	MESH:D017114
17919553	1670	1685	toxic hepatitis	MESH:D056486
17919553	1701	1710	hepatitis	MESH:D006505
17919553	1898	1913	acute hepatitis	MESH:D017114
15632880	23	42	renal insufficiency	MESH:D051437
15632880	47	59	hyperkalemia	MESH:D006947
15632880	77	90	heart failure	MESH:D006333
15632880	183	196	heart failure	MESH:D006333
15632880	229	241	hyperkalemia	MESH:D006947
15632880	251	270	renal insufficiency	MESH:D051437
15632880	300	313	heart failure	MESH:D006333
15632880	535	547	hyperkalemia	MESH:D006947
15632880	552	571	renal insufficiency	MESH:D051437
15632880	575	588	heart failure	MESH:D006333
15632880	611	625	spironolactone
15632880	673	686	heart failure	MESH:D006333
15632880	709	723	spironolactone
15632880	784	796	hyperkalemia	MESH:D006947
15632880	818	837	renal insufficiency	MESH:D051437
15632880	1110	1124	spironolactone
15632880	1132	1144	hyperkalemia	MESH:D006947
15632880	1157	1170	renal failure	MESH:D051437
15632880	1204	1216	hyperkalemia	MESH:D006947
15632880	1454	1473	renal insufficiency	MESH:D051437
15632880	1671	1706	Spironolactone-induced hyperkalemia	MESH:D006947
15632880	1711	1730	renal insufficiency	MESH:D051437
11773892	0	23	End-stage renal disease	MESH:D007676
11773892	25	29	ESRD	MESH:D007676
11773892	436	459	end-stage renal disease	MESH:D007676
11773892	461	465	ESRD	MESH:D007676
11773892	533	537	ESRD	MESH:D007676
11773892	542	563	chronic renal failure	MESH:D007676
11773892	573	577	OLTX
11773892	565	568	CRF
11773892	588	595	METHODS
11773892	1155	1172	renal dysfunction	MESH:C535382
11773892	1249	1253	ESRD	MESH:D007676
11773892	1350	1370	hepatorenal syndrome	MESH:D006530
11773892	1762	1765	CRF
11773892	2345	2349	ESRD	MESH:D007676
11773892	2414	2422	dialysis
11773892	2533	2558	have hepatorenal syndrome	MESH:D006530
11773892	2675	2678	CRF
10835440	512	520	ischemic	MESH:D002545
10835440	1027	1039	diastolic BP	MESH:D006337
10835440	1041	1044	DBP	MESH:C536663
9523805	36	53	spinal anesthesia	MESH:C535694
9245658	40	62	cardiovascular disease	MESH:D002318
9245658	150	172	cardiovascular disease	MESH:D002318
9245658	270	285	atherosclerosis	MESH:D050197
9245658	684	694	thrombosis	MESH:D013927
8437969	183	199	bradyarrhythmias	MESH:D001919
8437969	224	232	leukemia	MESH:D007938
8437969	251	266	cardiac disease	MESH:D006331
8437969	391	402	arrhythmias	MESH:D001145
7890216	1802	1832	spontaneous gall stone disease	MESH:D042882
7199841	377	390	neurotoxicity	MESH:D020258
7199841	721	740	hind-limb paralysis	MESH:D010264
7199841	956	972	subpial necrosis	MESH:D009336
6640832	41	58	bladder carcinoma	MESH:D001745
6640832	115	154	superficial transitional cell carcinoma	MESH:D002295
6640832	273	278	TA-T1	MESH:C538397
6640832	285	299	bladder tumors	MESH:D001749
6640832	552	569	chemical cystitis	MESH:D003556
6640832	1048	1054	tumors	MESH:D009369
3560096	0	12	Hyperkalemia	MESH:D006947
3560096	47	59	Hyperkalemia	MESH:D006947
3560096	354	366	hyperkalemia	MESH:D006947
3560096	726	738	hyperkalemia	MESH:D006947
3560096	863	868	NSAID	MESH:D055963
3358181	0	28	Ventricular tachyarrhythmias	MESH:D013610
3358181	473	494	cardiovascular status	MESH:D002318
3358181	854	865	tachycardia	MESH:D013610
2887062	70	104	estrogen-induced rat prolactinomas	MESH:D015175
2887062	613	625	prolactinoma	MESH:D015175
2887062	1095	1107	prolactinoma	MESH:D015175
2887062	1555	1562	adenoma	MESH:D000236
2425813	161	172	Wistar rats	MESH:D011906
2375138	281	306	cardiovascular depression	MESH:D002318
2265898	0	15	Serial epilepsy	MESH:D004827
2265898	26	34	levodopa
2265898	79	91	hemodialysis
2265898	178	191	renal failure	MESH:D051437
2265898	196	208	hemodialysis
2265898	304	312	levodopa
2265898	352	364	hallucinosis	MESH:D000430
1085609	147	168	maternal tuberculosis	MESH:D014376
1085609	373	394	pyridoxine deficiency	MESH:D026681
809711	98	125	acute myocardial infarction	MESH:D009203
809711	194	221	acute myocardial infarction	MESH:D009203
809711	1259	1286	acute myocardial infarction	MESH:D009203
20621845	61	79	media degeneration	MESH:D010033
20621845	274	289	arterial injury	MESH:D020212
20621845	765	769	ADAM
20621845	1022	1040	media degeneration	MESH:D010033
20621845	1847	1866	vascular remodeling	MESH:D020257
19473225	102	129	Toxic peripheral neuropathy	MESH:D056486
19473225	289	317	ameliorate PAC neurotoxicity	MESH:C537560
19473225	430	440	neuropathy	MESH:D003929
19473225	544	558	ovarian cancer	MESH:D010051
19387625	72	94	secondary hyperalgesia	MESH:D006930
19387625	252	274	secondary hyperalgesia	MESH:D006930
19387625	521	543	secondary hyperalgesia	MESH:D006930
19387625	571	609	capsaicin-untreated, control condition	MESH:D007174
19387625	734	756	secondary hyperalgesia	MESH:D006930
19387625	761	770	attention	MESH:D001289
19211690	220	222	DS
19211690	236	238	HS	OMIM:182900
19211690	194	218	Dahl salt-sensitive rats	MESH:D011906
19211690	225	234	high-salt	MESH:D013651
19211690	386	388	DS
19211690	688	700	renal injury	MESH:D058186
19211690	717	719	LS	MESH:D007888
19211690	732	734	DS
19211690	707	715	low-salt	MESH:D009800
19211690	802	804	HS	OMIM:182900
19211690	951	953	DS
19211690	1025	1043	Radiotelemetric BP
19211690	1092	1094	LS	MESH:D007888
19211690	1101	1103	HS	OMIM:182900
19211690	1190	1210	glomerular sclerosis	MESH:D007673
19211690	1219	1221	DS
19211690	1303	1305	DS
19211690	1325	1337	renal injury	MESH:D058186
19211690	1397	1399	HS	OMIM:182900
19211690	1470	1482	renal injury	MESH:D058186
19211690	1491	1493	DS
19211690	1502	1504	HS	OMIM:182900
18703024	215	228	schizophrenia	MESH:D012559
18703024	390	403	schizophrenia	MESH:D012559
18703024	672	681	catalepsy	MESH:D002375
18703024	731	733	PD	OMIM:168600
18703024	1246	1259	schizophrenia	MESH:D012559
18631865	24	35	proteinuria	MESH:D011507
18631865	294	315	allograft nephropathy	OMIM:161900
18631865	473	484	proteinuria	MESH:D011507
18631865	754	782	segmental glomerulosclerosis	MESH:C538457
18631865	987	998	proteinuria	MESH:D011507
18162529	0	12	Hypothalamic	MESH:D007027
18162529	92	110	hyperprolactinemic
18162529	193	211	Hyperprolactinemia	MESH:D006966
18162529	223	232	fertility	MESH:D007246
18162529	377	403	chronic hyperprolactinemia	MESH:D006966
18162529	534	560	Chronic hyperprolactinemia	MESH:D006966
18162529	1207	1212	PRL-R	MESH:D015175
18162529	1527	1530	CIS
18162529	1671	1674	CIS
18162529	1760	1786	chronic hyperprolactinemia	MESH:D006966
17879945	18	48	cholesteryl ester accumulation	MESH:C531854
17879945	130	133	HIV	MESH:D015658
17879945	307	332	premature atherosclerosis	MESH:D050197
17879945	401	423	atherosclerotic lesion	MESH:D010302
17879945	577	607	cholesteryl ester accumulation	MESH:C531854
17879945	769	772	HIV	MESH:D015658
17879945	1983	2013	cholesteryl ester accumulation	MESH:C531854
17437408	442	445	BBB	OMIM:145410
17437408	421	440	blood-brain barrier	MESH:C536830
17437408	665	679	MRP2-deficient	MESH:D003677
17437408	719	730	Wistar rats	MESH:D011906
17437408	1199	1202	BBB	OMIM:145410
17437408	1254	1265	Wistar rats	MESH:D011906
17437408	1360	1371	Wistar rats	MESH:D011906
17437408	2029	2040	Wistar rats	MESH:D011906
17437408	2362	2377	MRP2 deficiency	MESH:D003677
17242861	538	541	CSS
17242861	796	799	CSS
16337777	105	132	Mitochondrial abnormalities	MESH:D028361
16337777	527	529	FR
16337777	1159	1162	CCO	MESH:D020512
16337777	1231	1258	mitochondrial abnormalities	MESH:D028361
16337777	1378	1412	determined important abnormalities	MESH:D003643
15859940	16	42	thrombotic microangiopathy	MESH:D057049
15859940	101	127	Thrombotic microangiopathy	MESH:D057049
15859940	227	253	thrombotic microangiopathy	MESH:D057049
15859940	279	304	hemolytic uremic syndrome	MESH:D006463
15859940	342	368	thrombotic microangiopathy	MESH:D057049
15859940	502	528	thrombotic microangiopathy	MESH:D057049
15859940	824	850	thrombotic microangiopathy	MESH:D057049
15859940	1202	1228	thrombotic microangiopathy	MESH:D057049
15859940	1243	1268	antiphospholipid syndrome	MESH:D016736
15859940	1287	1315	systemic lupus erythematosus	MESH:D008180
15859940	1386	1401	uremic syndrome	MESH:D006463
15859940	1467	1492	hemolytic uremic syndrome	MESH:D006463
15859940	1660	1686	thrombotic microangiopathy	MESH:D057049
15859940	1778	1804	thrombotic microangiopathy	MESH:D057049
15188772	48	69	diastolic dysfunction	MESH:D006337
15188772	88	119	iatrogenic epinephrine overdose	MESH:D015537
15188772	143	157	cardiomyopathy	MESH:D009202
15188772	291	313	myocardial dysfunction	MESH:D009202
15188772	563	588	left ventricular systolic	MESH:D018487
15188772	593	614	diastolic dysfunction	MESH:D006337
15188772	666	685	myocardial necrosis	MESH:D009336
15130900	0	22	Urinary bladder cancer	MESH:D001749
15130900	26	50	Wegener's granulomatosis	MESH:D014890
15130900	142	156	bladder cancer	MESH:D001749
15130900	213	237	Wegener's granulomatosis	MESH:D014890
15130900	342	366	Wegener's granulomatosis	MESH:D014890
15130900	426	441	Cancer Register	MESH:D009369
15130900	486	500	bladder cancer	MESH:D001749
15130900	644	658	bladder cancer	MESH:D001749
15130900	738	752	bladder cancer	MESH:D001749
15130900	759	783	Wegener's granulomatosis	MESH:D014890
15130900	829	843	bladder cancer	MESH:D001749
15130900	872	896	Wegener's granulomatosis	MESH:D014890
15130900	1066	1080	bladder cancer	MESH:D001749
15130900	1325	1339	bladder cancer	MESH:D001749
15130900	1394	1418	Wegener's granulomatosis	MESH:D014890
15130900	1437	1451	bladder cancer	MESH:D001749
15130900	1532	1556	Wegener's granulomatosis	MESH:D014890
15130900	1661	1675	bladder cancer	MESH:D001749
15130900	1794	1808	granulomatosis	MESH:C531653
12707296	36	65	cortisol-induced hypertension	MESH:C535280
12707296	69	109	deficient L-arginine-nitric oxide system	MESH:D028361
12707296	127	156	cortisol-induced hypertension	MESH:C535280
12707296	198	215	L-arginine uptake	MESH:C536778
12695819	341	343	DW
12695819	741	767	white matter abnormalities	MESH:D056784
12695819	886	912	white matter abnormalities	MESH:D056784
12695819	1098	1114	normal ADC value	MESH:C537354
12695819	1153	1178	cortical laminar necrosis	MESH:D007673
12695819	1285	1298	neurotoxicity	MESH:D020258
12596116	19	28	hypoxemia	MESH:D000860
12596116	33	55	pulmonary hypertension	MESH:D006976
11875660	179	190	anencephaly	MESH:D000757
11875660	192	203	Anencephaly	MESH:D000757
11875660	766	777	anencephaly	MESH:D000757
11875660	1954	1965	anencephaly	MESH:D000757
8701950	17	33	hemolytic anemia	MESH:D000743
8701950	101	134	microangiopathic hemolytic anemia	MESH:D011697
8701950	136	140	MAHA
7292072	8	31	ventricular tachycardia	MESH:D017180
7292072	85	108	ventricular tachycardia	MESH:D017180
7292072	166	176	arrhythmia	MESH:D001145
7292072	279	282	QRS	MESH:D008151
7292072	316	343	intraventricular conduction	MESH:C535853
7292072	377	380	QRS	MESH:D008151
7292072	410	433	ventricular tachycardia	MESH:D017180
7292072	492	515	ventricular tachycardia	MESH:D017180
2484011	1864	1886	catecholamine turnover	MESH:C536334
2396046	174	193	choline-devoid diet	MESH:D002796
2396046	329	373	choline-devoid or choline-supplemented diets	MESH:D002796
2396046	425	475	preneoplastic nodules or hepatocellular carcinomas	MESH:D006528
2396046	574	598	hepatocellular carcinoma	MESH:D006528
2396046	682	736	preneoplastic nodules and of hepatocellular carcinomas	MESH:D006528
2396046	999	1026	Sporadic neoplastic lesions	MESH:D009386
2008831	566	574	ischemic	MESH:D002545
1732369	72	91	myocardial function	MESH:D009202
1732369	151	167	childhood cancer	MESH:C536928
1732369	246	278	acute and chronic cardiomyopathy	MESH:D009202
1732369	498	504	cancer	MESH:D009369
234669	110	129	Cardiac arrhythmias	MESH:D001145
234669	269	289	cardiac disturbances	MESH:D006331
234669	664	686	ventricular myocardium	MESH:D056830
234669	1318	1341	ventricular arrhythmias	MESH:D001145
16740173	832	843	Bradycardia	MESH:D001919
16740173	845	865	cholinergic symptoms	MESH:C535672
16740173	956	1005	adrenaline (epinephrine), atropine and furosemide
16740173	1078	1093	bradyarrhythmic
16740173	1138	1151	hyperhidrosis	MESH:D006945
16740173	1153	1168	hypersalivation	MESH:D012798
16740173	1170	1183	bronchorrhoea
16740173	1196	1202	miosis	MESH:D015877
16740173	1241	1271	atrio-ventricular dissociation	MESH:D004213
16740173	1413	1431	increased dyspnoea	MESH:D019586
16740173	1476	1501	Respiratory insufficiency	MESH:D012131
16740173	1526	1543	Proteus mirabilis	MESH:D016715
16740173	1738	1751	heart failure	MESH:D006333
16740173	2495	2523	acute cardiovascular failure	MESH:D002318
6203452	0	26	Thrombotic microangiopathy	MESH:D057049
6203452	31	44	renal failure	MESH:D051437
6203452	61	75	antineoplastic
6203452	109	118	carcinoma	MESH:D002277
6203452	129	155	thrombotic microangiopathy	MESH:D057049
6203452	174	193	renal insufficiency	MESH:D051437
6203452	212	228	hemolytic anemia	MESH:D000743
6203452	234	258	usually thrombocytopenia	MESH:D013921
6203452	388	413	hemolytic-uremic syndrome	MESH:D006463
6203452	656	661	tumor	MESH:D009369
6203452	687	692	tumor	MESH:D009369
6203452	728	754	thrombotic microangiopathy	MESH:D057049
6203452	939	952	renal failure	MESH:D051437
6203452	1005	1011	anemia	MESH:D000740
6203452	1016	1032	thrombocytopenia	MESH:D013921
20528871	88	129	paediatric T-cell lymphoblastic leukaemia	MESH:D054218
20528871	134	142	lymphoma	MESH:D008223
20528871	356	372	T-cell leukaemia	MESH:D015458
20528871	376	384	lymphoma	MESH:D008223
20528871	481	491	neuropathy	MESH:D003929
20528871	518	541	Haematological toxicity	MESH:D056486
20528871	968	989	neurological toxicity	MESH:D056486
11672959	81	108	constellation of dermatitis	MESH:D003872
11672959	110	115	fever	MESH:D005334
11672959	117	132	lymphadenopathy	MESH:D008206
11672959	137	146	hepatitis	MESH:D006505
11672959	227	247	rheumatoid arthritis	MESH:D001172
11672959	321	346	necrotising lymphadenitis	MESH:D020042
11672959	364	383	erythrophagocytosis
11672959	398	422	eosinophilic infiltrates	MESH:C535944
11672959	532	541	hepatitis	MESH:D006505
11672959	833	864	massive hepatocellular necrosis	MESH:D047508
11672959	872	900	hypersensitivity myocarditis	MESH:D009205
11672959	934	943	nephritis	MESH:D009393
11672959	1137	1160	sulphasalazine syndrome	MESH:D013577
11928786	386	406	symptoms of toxicity	MESH:D056486
11928786	433	444	tachycardia	MESH:D013610
11928786	520	539	cardiac arrhythmias	MESH:D001145
11928786	879	904	broad complex tachycardia	MESH:D013610
11928786	971	1011	neurological and cardiovascular toxicity	MESH:D056486
19300402	145	164	diabetic neuropathy	MESH:D003929
19300402	714	724	neuropathy	MESH:D003929
19300402	1062	1083	diabetic hyperalgesia	MESH:D006930
19300402	1357	1369	hyperalgesia	MESH:D006930
19300402	1512	1522	neuropathy	MESH:D003929
19300402	1654	1683	diabetic and toxic neuropathy	MESH:D056486
19300402	1711	1723	hyperalgesia	MESH:D006930
19300402	1833	1845	hyperalgesia	MESH:D006930
19300402	1998	2000	NO	MESH:D002311
19300402	2056	2067	neuropathic	MESH:D009437
15325671	0	16	Cardiac toxicity	MESH:D056486
15325671	96	120	metastatic breast cancer	MESH:D001943
15325671	258	297	nonhematological dose-limiting toxicity	MESH:D056486
15325671	301	315	cardiomyopathy	MESH:D009202
15325671	482	506	metastatic breast cancer	MESH:D001943
15325671	572	596	metastatic breast cancer	MESH:D001943
15325671	746	770	congestive heart failure	MESH:D006333
15325671	772	775	CHF
15325671	927	944	diabetes mellitus	MESH:D003920
15325671	1080	1083	CHF
15325671	1204	1245	cyclophosphamide-related cardiac toxicity	MESH:D056486
15325671	1347	1350	CHF
15325671	1716	1719	CHF
1992636	0	16	Hemolytic anemia	MESH:D000743
1992636	245	258	ulcer disease	MESH:D014456
1992636	260	278	reflux esophagitis	MESH:D005764
1992636	288	314	Zollinger-Ellison syndrome	MESH:D015043
1992636	550	566	hemolytic anemia	MESH:D000743
1992636	590	598	weakness	MESH:D018908
1992636	614	635	shortness of breath 2	MESH:D004417
1992636	1019	1035	hemolytic anemia	MESH:D000743
8387218	547	551	AIDS	MESH:D000163
8387218	1158	1168	neuropathy	MESH:D003929
8387218	1197	1209	pancreatitis	MESH:D010195
20698227	67	83	hemolytic anemia	MESH:D000743
20698227	257	272	acute hemolysis	MESH:D006461
20698227	458	464	anemia	MESH:D000740
20698227	519	528	hepatitis	MESH:D006505
20698227	1297	1303	anemia	MESH:D000740
20698227	1321	1330	hepatitis	MESH:D006505
20477932	399	425	sensor of oxidative stress	MESH:D054549
9495837	62	88	cholinergic amplifier PG-9	MESH:C535672
9495837	653	691	acetylcholine depletor hemicholinium-3	OMIM:608931
1468485	78	98	hemorrhagic cystitis	MESH:D003556
1468485	132	152	hemorrhagic cystitis	MESH:D003556
1468485	189	213	Wegener's granulomatosis	MESH:D014890
1468485	568	577	hematuria	MESH:D006417
1468485	751	771	hemorrhagic cystitis	MESH:D003556
1009330	319	327	cystitis	MESH:D003556
1009330	422	438	erosive cystitis	MESH:D003556
1009330	557	573	erosive cystitis	MESH:D003556
347884	1012	1031	psychotic syndromes	MESH:D011618
347884	1063	1076	schizophrenia	MESH:D012559
20667451	0	42	Curcumin ameliorates cognitive dysfunction	MESH:D003072
20667451	821	832	Wistar rats	MESH:D011906
19767176	1390	1403	neuronal loss	MESH:D016388
16330293	680	693	heart disease	MESH:D006331
16330293	745	762	diabetes mellitus	MESH:D003920
14568327	32	67	dyskinesias in parkinsonian monkeys	MESH:D008992
14568327	135	163	Levodopa-induced dyskinesias	MESH:D004409
14568327	248	250	PD	OMIM:168600
14568327	227	246	Parkinson's disease	MESH:D010300
14568327	165	169	LIDs	MESH:C537738
14568327	1087	1097	dyskinesia	MESH:D020820
11250767	126	138	pericarditis	MESH:D010493
11250767	198	208	vasculitis	MESH:D014657
11250767	226	238	pericarditis	MESH:D010493
11250767	298	313	hyperthyroidism	MESH:D006980
11250767	366	378	pericarditis	MESH:D010493
11250767	391	409	glomerulonephritis	MESH:D005921
11250767	972	984	pericarditis	MESH:D010493
11250767	1079	1091	Pericarditis	MESH:D010493
11250767	1141	1151	vasculitis	MESH:D014657
11206082	265	267	BS	MESH:D001816
11206082	869	871	BS	MESH:D001816
11027905	44	50	cancer	MESH:D009369
11027905	396	407	neuropathic	MESH:D009437
11027905	503	509	cancer	MESH:D009369
11027905	1699	1710	neuropathic	MESH:D009437
9334596	38	58	erectile dysfunction	MESH:D007172
9334596	232	252	erectile dysfunction	MESH:D007172
9334596	488	510	hormonal abnormalities	OMIM:609698
9334596	714	726	gynecomastia	MESH:D006177
9334596	921	941	erectile dysfunction	MESH:D007172
9334596	1099	1111	gynecomastia	MESH:D006177
9334596	1238	1256	hyperprolactinemia	MESH:D006966
9334596	1483	1499	pituitary tumors	MESH:D010911
9334596	1625	1649	hypothalamic dysfunction	MESH:D007027
9334596	1741	1761	erectile dysfunction	MESH:D007172
9334596	2233	2245	prolactinoma	MESH:D015175
9334596	2400	2413	prolactinomas	MESH:D015175
9334596	2767	2794	erectile dysfunction cannot	MESH:D007172
9334596	2962	2978	pituitary tumors	MESH:D010911
9334596	3240	3252	gynecomastia	MESH:D006177
8595686	446	463	Venous discomfort	MESH:D014647
8595686	836	853	venous discomfort	MESH:D014647
8595686	1034	1037	VAS	MESH:C535984
6466532	68	79	bradycardia	MESH:D001919
6466532	84	95	arrhythmias	MESH:D001145
6466532	334	344	arrhythmia	MESH:D001145
6466532	349	360	bradycardia	MESH:D001919
2870085	777	810	isoproterenol-induced tachycardia	MESH:D013610
2870085	1101	1111	heart rate	MESH:D006331
2870085	1129	1161	supraventricular tachyarrhythmia	MESH:D013610
1639466	62	77	nephrosclerosis	MESH:D009400
1639466	91	116	renovascular hypertension	MESH:D006978
1639466	273	284	albuminuria	MESH:D000419
1639466	286	304	renal hemodynamics	MESH:D007680
1639466	392	417	renovascular hypertension	MESH:D006978
1639466	451	463	renal artery	MESH:D012078
1639466	748	766	renal hemodynamics	MESH:D007680
1639466	799	811	renal plasma	MESH:D054219
1639466	925	934	sclerosis	MESH:D012598
1639466	1102	1114	Renal plasma	MESH:D054219
1639466	1157	1175	glomerulosclerosis	MESH:D003928
1639466	1265	1276	albuminuria	MESH:D000419
220563	0	19	Perhexiline maleate
220563	35	45	neuropathy	MESH:D003929
220563	47	68	Peripheral neuropathy	MESH:D010523
220563	407	429	demyelinating disorder	MESH:D003711
220563	625	635	neuropathy	MESH:D003929
137340	337	350	hyperactivity	MESH:D006948
137340	898	911	hyperactivity	MESH:D006948
9931093	199	213	nephrotoxicity
20067456	274	297	male sexual dysfunction	MESH:D007172
20067456	366	368	SD	MESH:D029461
20067456	1903	1905	SD	MESH:D029461
18464113	33	42	hepatitis	MESH:D006505
18464113	116	122	cancer	MESH:D009369
18464113	167	184	Hepatitis B virus	MESH:D006509
18464113	186	189	HBV	MESH:D006509
18464113	229	242	liver disease	MESH:D008107
18464113	254	260	Cancer	MESH:D009369
18464113	298	301	HBV	MESH:D006509
18464113	458	464	cancer	MESH:D009369
18464113	493	519	hematological malignancies	MESH:D019337
18464113	525	546	chronic HBV infection	MESH:D006509
18464113	1254	1263	hepatitis	MESH:D006505
18464113	1311	1320	hepatitis	MESH:D006505
18464113	1366	1375	hepatitis	MESH:D006505
18464113	1443	1469	Comparison of the mean ALT
18464113	1761	1767	cancer	MESH:D009369
18308784	1092	1095	LTP
18308784	1068	1090	long-term potentiation	MESH:D008133
18308784	1517	1542	spatial learning capacity	MESH:D007859
17931375	94	97	AIM
17931375	1050	1053	VAS	MESH:C535984
17931375	1029	1048	visual analog scale	MESH:D012640
15649445	108	128	orofacial dyskinesia	MESH:D009069
15649445	173	193	orofacial dyskinesia	MESH:D009069
15649445	224	242	tardive dyskinesia	MESH:D009069
15649445	244	246	TD	MESH:C536507
15649445	378	398	orofacial dyskinesia	MESH:D009069
15649445	1227	1247	orofacial diskinesia	MESH:D005157
14698717	94	103	psychosis	MESH:D011618
12617329	1097	1122	proximal tubular necrosis	MESH:D005198
12617329	1375	1392	GM nephrotoxicity	OMIM:606824
12617329	1501	1514	renal failure	MESH:D051437
12523465	434	442	epilepsy	MESH:D004827
11961407	56	65	nephrosis	MESH:D009401
11961407	451	468	glomerular injury	MESH:D007673
11961407	1021	1039	glomerulosclerosis	MESH:D003928
9401499	20	35	aplastic anemia	MESH:D000741
9401499	163	178	aplastic anemia	MESH:D000741
9401499	858	873	aplastic anemia	MESH:D000741
10683478	417	428	hypothermia	MESH:D007035
10683478	719	732	hyperactivity	MESH:D006948
10683478	912	923	hypothermia	MESH:D007035
10683478	1316	1340	Dopamine turnover ratios	MESH:D013580
10683478	1524	1550	striatal dopamine turnover	MESH:D013580
